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Abstract: Chromosomal instability is a major pathway of sporadic colon carcinogenesis. 
Chromosome arm 1p appears to be one of the “hot spots” in the non-neoplastic mucosa that, 
when deleted, is associated with the initiation of carcinogenesis. Chromosome arm 1p contains 
genes associated with DNA repair, spindle checkpoint function, apoptosis, multiple   microRNAs, 
the Wnt signaling pathway, tumor suppression, antioxidant activities, and defense against 
environmental toxins. Loss of 1p is dangerous since it would likely contribute to genomic 
instability leading to tumorigenesis. The 1p deletion-associated colon carcinogenesis pathways 
are reviewed at the molecular and cellular levels. Sporadic colon cancer is strongly linked to a 
high-fat/low-vegetable/low-micronutrient, Western-style diet. We also consider how selected 
dietary-related compounds (eg, excess hydrophobic bile acids, and low levels of folic acid, niacin, 
plant-derived antioxidants, and other modulatory compounds) might affect processes leading 
to chromosomal deletions, and to the molecular and cellular pathways specifically altered by 
chromosome 1p loss.
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Introduction
Chromosomal instability is a major feature of sporadic colon carcinogenesis.1–11 
  Eighty-five percent of colorectal cancers are aneuploid, the remaining 15% being 
diploid.5 Chromosome 1p deletions in colon tumors have been reported by laboratories 
from at least 15 countries around the world.12–49 Chromosome 1p deletions occur at 
an early stage of colon carcinogenesis,21,24,26–28,30,31,33,37,39,41–45 and are strongly linked to 
karyotypic evolution during colon cancer development.43
Many reports in the literature indicate that the macroscopically normal mucosa 
proximal or distal to a colon cancer exhibit aneuploidy (loss or gain of chromosomes or 
parts of chromosomes). Relevant to this review, Cianciulla et al44 reported that deletions 
of chromosome 1p were simultaneously found in both the distant   normal-appearing 
mucosa of 76% of patients who also harbored 1p deletions in their cancer. These 
  findings indicate that the loss of chromosome 1p may be one of the “hot spots” among 
the numerous defects in the non-neoplastic mucosa associated with the possible 
  initiation of colon carcinogenesis.50–70
The pioneering work of Paraskeva et al71–75 indicated the likely involvement 
of   chromosome 1p loss in in vitro immortalization72,74 and in the progression 
of adenomas to carcinomas.75 The functional importance of loss of distal 1p in 
colon tumorigenesis was demonstrated in 1993 by Tanaka et al76 who introduced Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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chromosomal band 1p36 into colon carcinoma cells and 
found that their tumorigenicity was suppressed.
Chromosome 1p deletions can affect distinct   pathways 
of sporadic colon carcinogenesis, including both chromo-
somal instability and chromosomal instability-negative 
pathways. The underlying mechanisms associated with 
the loss of chromosome 1p that may contribute to genomic 
instabilty and drive colon carcinogenesis are loss of 
genes associated with DNA repair, spindle checkpoint 
  function, apoptosis, multiple microRNAs (miRNAs), the 
Wnt   signaling pathway, tumor suppression, antioxidant 
  activities, and defense against environmental toxins.77,78 
Since centromeric instability and resulting telomeric 
fusions have been proposed as a mechanism for the loss 
of chromosome 1p,79 the loss of genes located on chromo-
some 1p that function to ensure centromeric stability and 
telomere integrity, in turn, can exacerbate chromosomal 
instability throughout the genome. These 1p deletion-
associated pathways that may lead to colon carcinogenesis 
will be reviewed at the molecular and cellular levels, and 
dietary factors that affect these pathways (eg, excess hydro-
phobic bile acids, and low levels of folic acid, niacin, plant-
derived antioxidants, and other modulatory compounds) 
will be explored. It is likely that certain dietary factors 
prevent, initiate, or exacerbate genomic instability in 
colon epithelial cells and thus have importance for colon 
carcinogenesis.
Mechanisms of carcinogenesis 
associated with the loss  
of key genes on chromosome 1p
Chromosome 1, the longest human chromosome, is gene-
dense with 3141 genes.80 The genes located on chromosome 1 
were identified with the assistance of the Weizmann Institute 
of Science websites:
GeneLoc (www.genecards.weizmann.ac.il/geneloc/index.
shtml) and GeneCards – The Human Gene   Compendium 
(www.genecards.org). Genes located on the p arm of 
  chromosome 1 that are associated with protection against 
  oxidative stress, DNA damage, mitotic perturbations, 
  excessive cellular proliferation, development of apoptosis 
resistance, aberrant colonic cell differentiation, and 
  environmental toxicity have been tabulated and the function 
of the gene products described (Tables 1–8). Since many of 
these genes have tumor suppressive capabilities, the simulta-
neous loss caused by a 1p deletion could initiate the forma-
tion of neoplastic clones and enhance tumorigenesis through 
  Darwinian selection.8
Mechanisms protective against genomic 
instability
Cells with DNA damage, spindle damage, and dysfunctional 
telomeres signal DNA damage responses.81–84 These DNA 
damage responses include the activation of numerous 
checkpoints that arrest the damaged cells in the G1, S, G2, or 
M-phase of the cell cycle, depending upon the nature of the 
damage or dysfunction and the stage of the cell cycle of the 
target cell. DNA-damage checkpoints are activated following 
direct damage to DNA.85–91 Spindle assembly checkpoints are 
activated following damage to the mitotic machinery,85,92–98 
or as a result of DNA damage during mitosis.99 Telomere 
checkpoints are activated by defective telomeres.100–106 These 
checkpoints prevent the damaged cell from completing 
DNA replication and mitosis until all damage is repaired 
(Figure 1), and thus prevent 1) mutations that could be formed 
by replicating a damaged DNA template, 2) aneuploidy 
that could result from chromosome mis-segregation, and 
3) telomere fusions that result in anaphase bridges, broken 
chromosomes, and translocations as a consequence of the 
well-known breakage–fusion–bridge cycles.107–114
However, cells with excessive direct DNA damage,115–122 
massive chromosome loss or chromosomal imbalances,123 
prolonged activation or inhibition of the spindle checkpoint 
pathways,122–127 or excessively shortened or dysfunctional 
telomeres,128–140 initiate a cascade of molecular events that 
ultimately leads to either caspase-dependent cell death,141–143 
caspase-independent cell death,144 or a special form of 
apoptosis referred to as mitotic catastrophe145–148 (Figure 2). 
(Brightfield micrographs are shown in Figure 3 illustrating 
the cellular alterations that accompany apoptosis [Figure 3A], 
mitotic perturbation [Figure 3B], mitotic catastrophe 
[Figure 3C], and micronuclei formation [associated with 
aneuploidy] [Figure 3D]). The cell-destructive and cell-
protective pathways are downstream of a common signal 
transduction network that responds to DNA damage.149 
The repair/survival and non-repair/cell death pathways are 
probably activated simultaneously.149 The repair, checkpoint, 
and cell death response to DNA damage are, however, 
well co-ordinated,150 the interplay of positive and negative 
regulatory loops resulting in a delayed death response to 
DNA damage.149
DNA repair and the DNA damage 
response (DDR) (Table 1)
The genes on chromosome 1p associated with DNA repair 
or the DNA damage response (DDR) include CLSN, DCL-
RE1B (APOLLO), DDI2, GADD45α, MSH4, MUTYH, Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 1 DNA repair and DNA damage response genes
Gene Function
CLSN Claspin homolog (Xenopus laevis); upstream regulator of checkpoint kinase 1 (Chk1) and triggers checkpoint arrest of 
the cell in response to inhibition of DNA replication or to DNA damage induced by ionizing and Uv radiation; binds 
specifically to BRCA1 and Chk1 and facilitates the ATR-dependent phosphorylation of both proteins; Chk1 is required to 
maintain Claspin stability; ring-shaped DNA-binding protein with high affinity for branched DNA structures and associates 
with S-phase chromatin following formation of the pre-replication complex; acts as a sensor which monitors the integrity 
of DNA replication forks.
DCLRE1B DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae); aliases: APOLLO, SNM1B; one of several evolutionarily conserved 
genes involved in the repair of interstrand cross-links which prevent strand separation, thereby blocking transcription, 
replication, and segregation of DNA; functions in the HSP70-mediated DNA damage response; APOLLO is stabilized 
when bound to the telomere-binding protein TRF2, and protects human telomeres in S phase; reduced levels result in 
an increased number of telomere-induced DNA damage foci and telomeric fusions in S-phase, suggesting that APOLLO 
contributes to a processing step associated with the replication of chromosome ends; interacts with astrin (microtubule 
binding protein) and is required for the prophase cell cycle checkpoint in response to spindle stress.
DDi2 DNA-damage inducible 1 homolog 2 (S. cerevisiae); protein has aspartic-type endopeptidase activity; very little is known as 
to the function of this gene product in the DNA damage response.
GADD45α Growth arrest and DNA-damage-inducible 45 alpha; multifunctional protein; responds to environmental stresses by 
mediating activation of the p38/JNK pathway via MTK1/MEKK4 kinase; the DNA damage-induced transcription of this 
gene is mediated by p53-dependent and -independent mechanisms; exhibits checkpoint function in response to oxidative 
DNA damage; responsive to p53 and modifies DNA accessibility on damaged chromatin; involved in base excision repair; 
stimulates DNA excision repair and inhibits entry of cells into S phase; level of expression modulated by glutathione 
peroxidase-1 and quercetin; deficiency associated with multidrug resistance; interacts with Aurora-A and inhibits its kinase 
activity; mediator of CD437-induced apoptosis; demethylation of 5′ CpG island in GADD45α leads to apoptosis; increased 
expression arrests the cell cycle at the G2/M phase; GADD45α-mediated apoptosis is activated by DNA mismatch repair; 
induces Bim dissociation from the cytoskeleton and translocation to mitochondria; regulates beta-catenin distribution and 
maintains cell-cell adhesion.
MSH4 MutS homolog 4 (E. coli); multifunctional protein; physically interacts with MSH5, MLH1, MLH3, RAD51, DMC1, and von 
Hippel-Lindau tumor suppressor-binding protein 1 during meiosis; required for reciprocal recombination and proper 
segregation of homologous chromosomes at meiosis; ATP binding by MSH4-MSH5 results in the formation of a sliding 
clamp that dissociates from the Holliday Junction crossover region embracing 2 duplex DNA arms; evidence is lacking at 
present for functional involvement of MSH4 and MSH5 in mismatch repair; in addition to meiosis, MSH4 and MSH5 are 
thought to play roles in mitotic DNA double strand break repair and the DNA damage response in human cells.
MUTYH MutY homolog (E. coli); DNA glycosylase involved in oxidative DNA damage repair; the enzyme excises adenine bases 
from the DNA backbone where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-deoxyguanosine  
(a major DNA lesion caused by oxidative stress); mutations in this gene result in heritable predisposition to colon and 
stomach cancer; the protein is localized to the nucleus and the mitochondria; excessive activity of MUTYH in response to 
oxidative DNA damage results in cell death. See text and Figure 4 for an in-depth discussion of the functions of MUTYH in 
base excision repair and cell death.
RAD54L RAD54-like (S. cerevisiae); aliases: HR54, hRAD54, RAD54A. DNA repair and recombination protein RAD54-like; protein 
product is a double-stranded DNA-dependent ATPase belonging to the DEAD-like helicase superfamily (Swi2/Snf2 protein 
family), and shares similarity with Saccharomyces cerevisiae Rad54, a protein involved in the repair of DNA double-strand 
breaks through homologous recombination; belongs to the RAD52 epistasis group that additionally includes RAD50, 
RAD51, RAD52, RAD55, RAD57, RAD59, MRE11, and Nbs1/XRS2; the binding of Rad54 to double-stranded DNA utilizes 
the energy from ATP hydrolysis to induce topological changes in DNA, believed to facilitate homologous DNA pairing and 
stimulate DNA recombination in the Rad52 DNA repair pathway; essential for strand invasion of the homologous donor 
sequence and may involve disruption or movement of nucleosomes (chromatin remodeling activity) that might block joint 
molecule formation and/or branch migration; dissociates Rad51 from nucleoprotein filaments formed on single-stranded 
DNA; Rad54 oligomers (dimer to particles .40 nm in diameter) possess a unique ability to cross-bridge or bind  
double-stranded DNA molecules positioned in close proximity. The combination of the cross-bridging and double-strand 
DNA translocation activities of Rad54 stimulates the formation of DNA networks, leading to rapid and efficient DNA 
strand exchange by Rad51; also plays an essential role in telomere length maintenance and telomere capping in mammalian 
cells through the Rad51 recombination pathway.
TP73 Tumor protein 73; member of the p53 family of transcription factors involved in cellular responses to stress; the family 
members include p53, p63, and p73 which have high sequence similarity to each other allowing p63 and p73 to 
transactivate p53-responsive genes causing cell cycle arrest and apoptosis; regulated by tyrosine kinase c-Abl in the 
apoptotic response to DNA damage; induces apoptosis via PUMA transactivation and Bax mitochondrial translocation; 
inactivated by human papillomavirus E6 proteins; has a role in mitotic exit and caspase-independent cell death; regulates 
DRAM-independent autophagy that does not contribute to programmed cell death; has a role in E2F1-induced apoptosis; 
may be a tumor suppressor protein.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 2 Mitosis-related and spindle checkpoint genes
Gene Protein function
APiTD1 Apoptosis-inducing, TAF9-like domain 1; centromere protein and component of the CENPA-CAD complex found at the 
distal nucleosome; this complex is recruited to centromeres where it is involved in the assembly of kinetochore proteins, 
mitotic progression and chromosome segregation; has a role in apoptosis.
AURKAiPi Aurora kinase A interacting protein 1; functions as a negative regulator of AURKA by degrading AURKA through several 
mechanisms involving the proteasomal pathway and ubiquitin-independent pathways involving antizyme 1; the inhibition of 
Aurora A has the effect of canceling the mitotic delay that occurs as a result of perturbation of cellular microtubules.
CCDC28B Coiled-coil domain containing 28B; localizes to centrosomes and basal bodies.
CCNL2 Cyclin L2; a novel RNA polymerase ii-associated cyclin located in nuclear speckles; transcriptional regulator involved in 
regulating the pre-mRNA splicing process; contains a RS region (arginine-serine dipeptide repeat) within the C-terminal 
domain which is the hallmark of the SR family of splicing factors; co-localizes with splicing factors; pro-apoptotic protein 
which modulates the expression of a critical apoptotic factor, leading to apoptosis.
CDC2L1 Cell division cycle 2-like 1 (PiTSLRE proteins); aliases: CDK11B, p58CDC2L1, galactosyl transferase-associated protein 
kinase p58/GTA; a member of the p34Cdc2 protein kinase family known to be essential for eukaryotic cell cycle control; 
has multiple roles in cell cycle progression, cytokinesis, and apoptosis; during Fas or tumor necrosis factor-induced 
apoptosis, CDK11 p110 isoforms are cleaved by caspases.
CDC2L2 Cell division cycle 2-like 2 (PiTSLRE proteins); aliases: CDK11A, PiTSLRE protein kinase beta; this gene encodes a 
member of the p34Cdc2 protein kinase family and is in close proximity to CDC2L1, a nearly identical gene in the same 
chromosomal region; has multiple roles in cell cycle progression, cytokinesis (maintains sister chromatid cohesion) and 
apoptosis.
CDC7 Cell division cycle 7 homolog (S. cerevisiae); kinase activity of CDC7 is critical for the G1/S transition of the cell cycle; 
functions in replication stress and mediates Claspin phosphorylation in DNA replication checkpoint control.
CDC14A CDC14 cell division cycle 14 homolog A (S. cerevisiae); alias: dual specificity protein phosphatase CDC14A; required for 
centrosome separation, chromosome segregation and subsequent cytokinesis during cell division; phosphorylates the APC 
(anaphase-promoting complex) subunit FZR1/CDH1, thereby promoting APC-FZR1-dependent degradation of mitotic 
cyclins and subsequent exit from mitosis; interacts with and dephosphorylates tumor suppressor protein p53, thereby 
regulating p53 function; interacts with KiF20A to localize CDC14 to the midzone of the mitotic spindle.
CDC20 Cell division cycle 20 homolog (S. cerevisiae); acts as a regulatory protein by interacting with several proteins at multiple 
points in the cell cycle; required for 2 microtubule-dependent processes, nuclear movement prior to anaphase and 
chromosome separation; required for full ubiquitin ligase activity of the APC; regulated by MAD2L1 resulting in an inactive 
ternary complex (MAD2L1-CDC20-APC) in metaphase; in anaphase the binary complex (CDC20-APC) is active in 
degrading its targeted substrates.
CDC42 Cell division cycle 42; 25 kDa GTP binding protein; small GTPase of the Rho-subfamily which regulates multiple signaling 
pathways including cell cycle progression G1 to S; controls spindle orientation of adherent cells; antagonistic cross-talk 
between Rac and Cdc42 GTPases regulates generation of reactive oxygen species; Cdc42 is a substrate for caspases and 
influences Fas-induced apoptosis.
CDCA8 Cell division cycle associated 8; alias: BOREALIN; component of a chromosomal passenger complex (CPC) required for 
stability of the bipolar mitotic spindle; The CPC consists of survivin, CDCA8, iNCENP, and Aurora-B; the CPC functions 
at the centromere to ensure correct chromosome alignment and segregation; CDCA8 is required for chromatin-induced 
microtubule stabilization and spindle assembly; CDCA8 may be required to direct the CPC to centromeric DNA; major 
effector of the TTK kinase in the control of “attachment-error-correction” and chromosome alignment.
CDKN2C Cyclin-dependent kinase inhibitor 2C; alias: p-18-iNK4C; this protein is a member of the iNK family of cyclin-dependent 
kinase inhibitors; interacts strongly with CDK6 and weakly with CDK4 and prevents the activation of the CDK kinases; 
inhibits cell growth and proliferation in the presence of retinoblastoma protein 1 (RB1) and acts as a tumor suppressor.
CROCC Ciliary rootlet coiled-coil protein; aliases: rootletin, Tax1-binding protein 2, ROLT; major structural component of the 
ciliary rootlet; forms centriole-associated filaments and contributes to centrosome cohesion before mitosis; recombinant 
rootletin forms detergent-insoluble filaments radiating from the centrioles; the homopolymeric rootletin protofilaments 
bundle into variably shaped thick filaments; interacts with C-Nap1 and may function in centrosome cohesion by acting 
as a physical linker between the pair of centrioles/basal bodies; ciliary rootlet interacts with kinesin light chains and 
may provide a scaffold for kinesin-1 vesicular cargos; rootletin is phosphorylated by Nek2 kinase and is displaced from 
the centrosomes at the onset of mitosis, resulting in the binding of beta-catenin to rootletin-independent sites on 
centrosomes (an event that is required for centrosome separation); overexpression of rootletin in cells results in the 
formation of extensive fibers resulting in multinucleation, micronucleation and irregularity of nuclear shape and size, 
indicative of defects in chromosome separation.
E2F2 E2F transcription factor 2: member of the E2F family of transcription factors; transcription activator that binds DNA 
cooperatively with DP (differentiation regulated transcription factor proteins) through the E2 recognition site,  
5′-TTTC[CG]CGC-3′, found in the promoter region of a number of genes whose products are involved in cell cycle 
regulation
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Table 2 (Continued)
Gene Protein function
or in DNA replication; the E2F family plays a crucial role in the control of the cell cycle and action of tumor suppressor 
proteins (eg, p14 (ARF); binds specifically to unphosphorylated retinoblastoma protein pRB in G0/G1, leading to the 
repression of E2F target genes; subsequent phosphorylation of pRB by cyclin-dependent kinases in late G1 inactivates 
pRB, liberating free E2F, which then functions to activate the expression of target genes required for S-phase entry and 
cell cycle progression; although E2F1-3 transcription factors were classified as positive regulators of the cell cycle (E2F 
activators), they also cause transcriptional repression, indicating that their specific effects may be cell type-specific; represses 
the expression of survivin, a dual mediator of apoptosis resistance and cell cycle progression; can function as a tumor 
suppressor in epithelial tissues, perhaps by limiting proliferation in response to Myc; hemizygosity of the E2F2 locus is 
sufficient to increase tumor incidence in the Myc-transgenic mouse model of tumorigenesis in the skin and oral cavity.
HDAC1 Histone deacetylase 1: in addition to effects on gene expression, histone deacetylase activity plays an important role in 
regulating the assembly of kinetochores, the activation of the mitotic checkpoint and the process of cytokinesis; decreased 
activity or aberrant control of HDAC activity can result in altered kinetochore assembly by disrupting pericentromeric 
heterochromatin, failure of appropriate chromosome segregation, and defects in the mitotic spindle checkpoint, resulting 
in mitotic slippage and chromosome instability; HDACs 1, 2, and 4 are closely related Zn++-dependent enzymes; HDAC1 
is part of a complex that binds to the promoter of TBP-2 (thioredoxin binding protein-2), resulting in repression of TBP-2 
transcription, increasing the activity of thioredoxin and protecting cells against oxidative stress.
KiF1B Kinesin family member 1B; motor protein that transports mitochondria and synaptic vesicle precursors; involved in the 
movement of chromosomes during mitosis; functions as a haploinsufficient tumor suppressor by inducing apoptotic cell 
death; acts downstream of EglN3 to induce apoptosis.
KiF2C Kinesin family member 2C; aliases: MCAK (mitotic centromere-associated kinesin); Aurora B regulates MCAK at the 
mitotic centromere; phosphorylated by STK12 and regulates the association of centromeres and kinetochores; promotes 
the ATP-dependent removal of tubulin dimers from microtubules in association with the process of microtubule 
depolymerization and turnover; functions in chromosome segregation during mitosis; contains the microtubule tip 
localization signal (MtLS) motif; phosphorylated after DNA damage, probably by ATM or ATR.
KiF17 Kinesin family member 17; proteins of the kinesin family are microtubule-dependent molecular motors that transport 
organelles within cells and move chromosomes during cell division.
MAD2L2 Mitotic arrest deficient-like 2 (yeast)-Like 2; component of the mitotic spindle assembly checkpoint that, like MAD2, may 
prevent the onset of anaphase until all chromosomes are properly aligned at the metaphase plate; suppression of MAD2L2 
confers sensitivity to a range of DNA-damaging agents, especially a DNA cross-linker, such as cisplatin; in  
MAD2L2-depleted cells there is a significant decrease in the cisplatin-induced sister chromatid exchange rate, a marker 
for homologous recombination-mediated post-replication repair; Unlike MAD2, MAD2L2 has not been shown to have a 
dual-role mitotic/pro-apoptotic function; interacts with the small GTPase RAN, which may play a role in the control of the 
spindle checkpoint during mitosis and the regulation of nucleocytoplasmic trafficking during interphase.
PLK3 Polo-like kinase 3; aliases: FNK, PRK; multifunctional serine/threonine protein kinase involved in stress response pathways; 
required for entry into S phase; regulates the M phase of the cell cycle; activated by genotoxic stress, through a Chk3-
mediated priming phosphorylation followed by an ATM-mediated full activation; functions as a centrosome localization 
signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis; involved in checkpoint-mediated 
cell cycle arrest to ensure genetic stability; links DNA damage to cell cycle arrest and apoptosis, in part through the 
p53 pathway; may also be part of the signaling network that controls cellular adhesion.
PSRC1 Proline/serine-rich coiled-coil 1; alias: DDA3; functions as a microtubule destabilizing protein that controls spindle dynamics 
and mitotic progression by recruiting and regulating microtubule depolymerases; the N-terminal domain of PSRC1 regulates 
the spindle association of the microtubule depolymerase Kif2a and controls the mitotic function of PSRC1; regulated by p53 
and may participate in p53-mediated growth suppression; direct transcriptional target of p53 and p73.
RCC1 Regulator of chromosome condensation 1; a protein with a 7-bladed propeller structure that is involved in the regulation 
of onset of chromosome condensation in S phase; binds to chromatin and promotes the exchange of Ran-bound GDP 
by GTP; phosphorylation of RCC1 by cdc2 kinase in mitosis is essential for producing a high RanGTP concentration on 
chromosomes and for chromatin-induced mitotic spindle formation; perturbation of the chromosomal binding of RCC1, 
Mad2 and survivin causes spindle assembly defects and mitotic catastrophe; the RCC1/Ran complex, in conjunction with 
other proteins, acts as a component of a signal transmission pathway that detects unreplicated DNA.
RCC2 Regulator of chromosome condensation 2; alias: telophase disk protein of 60 kDa (TD-60); has an essential role in the 
prometaphase to metaphase progression and required for the completion of mitosis and signaling cytokinesis; may function   
as a guanine nucleotide exchange factor for the small GTPase RAC1; interacts with microtubules; appears in the nucleus 
at G2, then concentrates at the inner centromere region of chromosomes during prophase, then redistributes to the 
midzone of the mitotic spindle during anaphase where it covers the entire equatorial diameter from cortex to cortex; 
phosphorylated upon DNA damage, probably by ATM and ATR.
SASS6 Spindle assembly 6 Homolog (C. elegans); necessary for centrosome duplication and functions during procentriole 
formation to ensure that each centriole seeds the formation of a single procentriole per cell cycle; part of a ternary 
complex of SASS6, CENPJ, and CEP350.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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RAD54L, and TP73. The functions of these gene products 
are described in Table 1. The pathways that lead to the 
  prevention of genomic instability are diagrammatically 
shown in Figure 4. DNA damage elicits a well orchestrated 
and highly interactive series of events called the DDR, 
which causes cells to undergo growth arrest so that DNA 
damage can be adequately repaired. Although p53 mutation 
or loss of heterozygosity (LOH) is a late event in colon 
carcinogenesis,151 the loss of p73 (found on chromosome 1p) 
through chromosomal deletion events may act early in colon 
carcinogenesis. P73 is an important isoform of the p53 family, 
since it performs many of the transcriptional functions of p53, 
and may even target the same genes as p53 during the DDR. 
In addition, TP73 has distinct transcriptional targets and har-
monizes with p53 and p63 to maintain genomic stability.152–158 
In addition to its role in growth arrest after DNA damage to 
allow DNA repair to take place, p73 plays an active role in 
spindle dynamics, mitotic exit and chromosomal stability. 
The PSRC1 (proline/serine-rich coiled-coil 1) gene found 
on chromosome 1p (see Table 2) encodes a protein which is 
a direct transcriptional target of both p53 and p73.159 PSRC1 
functions as a microtubule destabilizing protein that controls 
spindle dynamics and mitotic progression by recruiting 
and regulating microtubule depolymerases.160 Through its 
transcriptional activity, p73 is important for the M-to-G1 
transition during mitosis.161 Functional knock-out of p73 gene 
expression by small interfering RNAs alters mitotic progres-
sion, resulting in an increase of ana-telophase cells, the accu-
mulation of aberrant late mitotic figures, and the appearance 
of abnormalities in the subsequent interphase.161 This novel 
pathway involves the p73-mediated transcription of Kip2/
p57, a cyclin-dependent kinase inhibitor, and the coordination 
of mitotic exit and transition to G1.161,162 Like p53, p73 has 
been confirmed to be a tumor suppressor.163–167 Therefore, a 
loss of p73 should have a major impact in the development 
of genomic instability during carcinogenesis.
Table 3 Apoptosis-related genes
Gene Protein function
BCL2L15 Bcl-2-like protein 15 has a pro-apoptotic function; alias Bfk; human bfk mRNA is found in cerebellum, colon, small intestine, 
testis, and uterus, but the protein is predominantly expressed in tissues of the gastrointestinal tract; in the transition from normal 
human colonic mucosal tissue to tumors, 80% of colon tumors show a substantially reduced expression of Bfk; gene expression 
appears to be regulated by female sex hormones.
BCL10 B-cell lymphoma 10; wild-type bcl10 is a pro-apoptotic protein that suppresses cellular transformation, whereas mutant forms 
lose this activity and display gain-of-function transforming activity; the bcl10 protein contains an amino-terminal CARD (caspase 
recruitment domain) found in many apoptotic-related molecules; the BCL10 gene often exhibits a frameshift mutation resulting 
in truncation distal to the CARD; has a high mutation frequency in hepatocellular carcinoma (57% of cases); the frequency 
of mutation in other cancers is as follows: lymphoma (45%), colon cancers with the microsatellite mutator phenotype (13%), 
mesothelioma, male germ cell tumors, adenocarcinoma cell lines (12%), gastric cancers with the microsatellite mutator phenotype 
(10%); the presence of the bcl10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral 
T-cell lymphomas and is associated with a better clinical outcome than bcl10-negative tumors.
CASP9 Caspase-9 (cysteine-aspartic acid protease, family member 9) precursor; aliases: APAF-3 (apoptotic protease-activating factor 3), 
apoptosis-related cysteine peptidase, MCH6, iCE-LAP6, iCE-like apoptotic protease 6; caspase-9 and APAF1 bind to each 
other via their respective NH2-terminal CED-3 homologous domains in the presence of cytochrome C and ATP to form the 
apoptosome, a high-molecular-weight complex; the caspase-9 precursor then becomes activated, which in turn activates the 
downstream caspases, caspase-3, and caspase-2, in response to genotoxic stress.
DFFA DNA fragmentation factor, 45 kD, alpha polypeptide; alias iCAD (inhibitor of caspase-activated DNase, DFFB); DFF is a 
heterodimeric protein consisting of 45 kD (DFFA) and 40 kD (DFFB) subunits; DFF becomes activated when DFFA is cleaved by 
caspase 3 and dissociates from DFFB (DFFB is the active component of DFF involved in both DNA fragmentation and chromatin 
condensation during the process of apoptosis [see below]).
DFFB DNA fragmentation factor, 40 kD, beta polypeptide (caspase-activated DNase; alias CPAN; enzyme activity is inhibited by 
DFFA; its Mg++-dependent endnuclease activity degrades DNA and induces DNA fragmentation; the fragmented DNA results 
in chromatin condensation during apoptosis, and is responsible for the typical crescents and margination of chromatin that are 
characteristic morphological features of the nucleus during apoptosis.
THAP3 THAP domain containing, apoptosis-associated protein 3; the THAP-family C(2)CH zinc-coordinating DNA-binding proteins 
function in diverse eukaryotic cellular processes, including transposition, transcriptional repression, stem-cell pluripotency, 
angiogenesis, neurological function, and apoptosis; the specific mechanism by which THAP3 contributes to apoptosis is unknown.
TNFRSF25 Tumor necrosis factor receptor superfamily, member 25; aliases: death receptor 3; DR3; translocating chain-association 
membrane protein; apoptosis inducing receptor; APO3; lymphocyte-associated receptor of death; LARD; apoptosis-mediating 
receptor TRAMP; a death domain-containing receptor related to TNFR-1 and CD95 (Apo-1/Fas); receptor for TNFSF12/
APO3L/TwEAK; interacts with the adaptor TRADD; DR3 signal transduction is mediated by a complex of intracellular signaling 
molecules including TRADD, TRAF2, FADD, and FLiCE.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 4 MicroRNAs (miRNAs) and components of the miRNA processing complex
MicroRNA Function
30c-1 A genetic variant of 30c-1 is associated with familial breast cancer in noncarriers of BRCA1/2 mutations.
30e A functional variant of pre-miRNA-30e is strongly associated with schizophrenia.
34a Major pro-apoptotic miRNA that is regulated by p53; induced by treatment of pancreatic β cells with iL-1β and  
TNF-α, and responsible, in part, for cytokine-triggered cell death; expression frequently lost in pancreatic ductal 
adenocarcinoma cells.
101-1 MiR-101 is downregulated in stage ii MSS and MSi colon cancers compared to normal mucosa, hepatocellular 
carcinoma, prostate cancer and transitional cell carcinoma of the bladder; miR-101 inhibits cell proliferation, represses 
the expression of the Polycomb group protein EZH2, and induces apoptosis.
137 MiR-137 exhibits decreased levels of expression in colon tumors compared to normal mucosa; frequently upregulated  
in rectal cancer in response to capecitabine chemoradiotherapy; changes level in reaction to xenobiotic challenge; 
targets MiTF (micropthalmia-associated transcription factor) in melanoma cell lines.
186 Expression of miR-186 significantly reduces the abundance of FOXO1, a tumor suppressor, in endometrial cancer, 
resulting in deregulated cell cycle control and impaired apoptotic responses; downregulates expression of the  
pro-apoptotic purinergic P2X7 receptor; dysregulated in human myocardial infarction.
197 Target miRNAs not experimentally verified.
200a involved in the regulation of the wnt/β-catenin signaling pathway; miRNAs-200a, -200b, and -429 are all encoded  
on a 7.5 kb polycistronic primary miRNA transcript.
200b involved in the regulation of the wnt/β-catenin signaling pathway; miRNAs-200a, -200b, and -429 are all encoded  
on a 7.5 kb polycistronic primary miRNA transcript.
320b-1 MiR-320 shows highest expression in the proliferative compartment of the crypts; the decrease in miR-320 in stage 
ii colon cancers is predictive of a metastatic recurrence independent of age, differentiation grade, and histologic 
subtype; targets the transferrin receptor 1 and inhibits proliferation; expression of miRNA-320 in myocardial 
microvascular endothelial cells (MMEC) impairs angiogenesis by decreasing proliferation and migration of MMEC; 
overexpression of miR-320 in mouse hearts increases apoptosis and infarction; targets heat-shock 20 mRNA; 
potentially targets the mRNA of the p85 subunit of phosphatidylinositol 3-kinase; exhibits a 50-fold increase in 
insulin-resistant 3T3-L1 adipocytes; affects cell cycle progression of bronchial epithelial cells exposed to benzo[a]
pyrene.
429 involved in the regulation of the wnt/β-catenin signaling pathway; miRNAs-200a, -200b, and -429 are all encoded on a 
7.5 kb polycistronic primary miRNA transcript; regulates the differential expression of miR200.
551a Target mRNAs not experimentally verified.
552 MiR-552 exhibits decreased levels of expression in proficient mismatch-repair colon tumors relative to deficient 
mismatch-repair tumors; target mRNAs not identified.
553 Target mRNAs not identified.
760 Regulated by 17β-estradiol and may affect a number of transcripts belonging to estrogen-responsive gene clusters.
942 Target mRNAs not experimentally verified.
1256 Target mRNAs not experimentally verified.
1262 Targets the HLA-G mRNA.
1290 Target mRNAs not experimentally verified.
1302-2 Controlled by the multifunctional Y-Box protein 1 (YB-1); upregulated more than 1.5-fold in drug-sensitive gastric 
carcinoma cells.
MiRNA processing
Ago1 Argonaute 1; aliases: protein argonaute 1, EiF2C1 (eukaryotic translation initiation factor 2C1), putative RNA-binding 
protein Q99, GERP95 (Golgi endoplasmic reticulum protein 95); encodes a member of the Argonaute family of 
proteins which binds to miRNAs and plays a role in gene silencing through RNA interference; may interact with dicer1; 
highly basic protein which contains a PAZ domain and a Piwi domain; found in a tandem cluster of closely related 
argonaute proteins, Ago3 and Ago4 on chromosome 1p; lacks endonuclease activity and does not appear to cleave 
target mRNAs.
Ago3 Argonaute 3; aliases: protein argonaute 3, EiF2C3 (eukaryotic translation initiation factor 2C3); encodes a member  
of the Argonaute family of proteins which binds to miRNAs and plays a role in gene silencing through RNA 
interference; highly basic protein which contains a PAZ domain and a Piwi domain; found in a tandem cluster of closely 
related argonaute proteins, Ago1 and Ago4 on chromosome 1p; lacks endonuclease activity and does not appear 
to cleave target mRNAs.
Ago4 Argonaute 4; aliases: protein argonaute 4, EiF2C4 (eukaryotic translation initiation factor 2C4); encodes a member  
of the Argonaute family of proteins which binds to miRNAs and plays a role in gene silencing through RNA 
interference; may interact with dicer1; highly basic protein which contains a PAZ domain and a Piwi domain; found in 
a tandem cluster of closely related argonaute proteins, Ago1 and Ago3 on chromosome 1p; lacks endonuclease activity 
and does not appear to cleave target mRNAs.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Since base excision repair (BER) removes damage that 
would otherwise be mutagenic in mammalian cells,168–170 
BER is one of the most important DNA repair pathways in 
the gastrointestinal tract. BER ameliorates environmentally 
induced DNA damage in addition to the alkylation, oxidation, 
and deamination events that occur during normal metabolic 
processes.171,172 A critical enzyme in the base excision 
repair pathway is MUTYH (MutY homolog or A/G-specific 
adenine DNA glycosylase), whose germline mutation is 
a known cause of MAP (MutYH-associated polyposis), a 
recently described autosomal recessive colorectal adenoma 
predisposition syndrome with a very high risk of colorectal 
cancer.173 Myh deficiency enhances intestinal tumorigenesis in 
multiple intestinal neoplasia (ApcMin/+) mice.174 Interestingly, 
Myh deficiency in mice has a larger effect on tumor initiation 
than on progression in the small bowel.174 Since 1p deletions 
are observed in the human non-neoplastic mucosa of patients 
with colon cancer,44 it is possible that Myh-deficient field 
defects may initiate the process of colon carcinogenesis in 
humans as it does in the mouse model. Since MUTYH-null 
mouse embryonic stem cells exhibit a mutator phenotype,175 
the loss of MUTYH can affect multiple pathways associated 
with colon carcinogenesis. The role of MUTYH in the repair 
of oxidative DNA damage begins with the formation of 
8-oxo-guanine (8-oxoG) (see Figure 4), which then causes 
a mispairing of the oxidized guanine base with adenine upon 
DNA replication. Mismatch repair processes are activated 
and MUTYH excises adenine leaving an apurinic (AP) site 
resulting, after AP endonuclease action, in a DNA single 
strand (ss) break.176–180 The activity of MUTYH, in conjunc-
tion with other glycosylases and the spontaneous generation 
of AP sites, may be quite extensive, since about 9000 AP 
sites/cell occur daily.168 The AP site is then correctly repaired 
by the sequential action of several enzymes which catalyze 
template-directed insertion of one or a few nucleotides at the 
previously damaged site.172
In addition to their role in DNA repair or the DDR, 
MUTYH and p73 play important roles in the death of cells 
that experience either excessive oxidative DNA damage or 
chromosomal instability. The MUTYH-mediated cell death 
pathway is described in the next section followed by a sec-
tion on the p73-mediated cell death pathway, which utilizes 
part of the MUTYH pathway in its mediation of cell death 
in response to excessive mitotic perturbation.
MUTYH/PARP/AiF pathway of cell death
MUTYH-mediated cell death has, as a central player, the activa-
tion of PARP-1 [poly(ADP-ribose) polymerase-1] (Figure 5). 
Table 5 Genes associated with the wnt signaling pathway
Gene Protein function
CTNNBiP1 Catenin, beta interacting protein 1: aliases: iCAT (inhibitor of beta-catenin-interacting protein iCAT), inhibitor of beta-catenin and 
Tcf-4; 9-kDa negative protein regulator of the wnt signaling pathway; prevents interaction between beta-catenin and Tcf-4 family 
members, thereby repressing beta-catenin-Tcf-4-mediated transactivation; in intestinal tissue, iCAT is upregulated in the mature, 
non-dividing enterocyte lining the villi, and is absent in the beta-catenin/TCF signaling region of the crypts; does not protect the 
soluble pool of beta-catenin from degradation by the APC (adenomatous popyposis coli); has a pro-apoptotic function in certain 
situations (see text).
DvL1 Dishevelled-1; aliases: DvL, segment polarity protein dishevelled DvL-1; the human homolog of the Drosophila dishevelled gene 
(dsh) encodes a cytoplasmic phosphoprotein that regulates cell proliferation, acting as a transducer molecule for developmental 
processes; dishevelled family proteins are cytoplasmic mediators of the wnt/beta-catenin signaling pathway linked to cancer with Dvl 
considered to be a middle molecule in the pathway; Dvl, Axin and GSK form a ternary complex bridged by Axin, and Frat1 can be 
recruited into this complex by Dvl; the Dvl-binding domain of either Frat1 or Axin is able to inhibit wnt-1-induced LEF-1 activation, 
suggesting that the interactions between Dvl and Axin and between Dvl and Frat may be important for the wnt/beta-catenin signaling 
pathway; Wnt-1 appears to promote the disintegration of the quaternary Frat1-Dvl-GSK-Axin complex, resulting in the dissociation 
of GSK from Axin and the formation of the Dvl/Frat-1 complex that leads to the activation of the wnt signaling pathway.
wNT2B wingless-type MMTv integration site family, 2B; aliases: wNT13, XwNT2, protein wnt-2b; member of the wNT family of highly 
conserved, secreted signaling factors that regulate cell growth and differentiation; ligand for members of the frizzled family of 
seven transmembrane receptors with an extracellular wNT-binding domain and a cytoplasmic dishevelled-binding domain; may be 
a signaling molecule that affects the development of discrete regions of tissues; is likely to signal over only a few cell diameters; 
wNT2B is one of the canonical wNTs transducing signals through Frizzled and LRP5/LRP6 receptors to beta-catenin-TCF/LEF 
signaling pathway; functions as a stem cell factor during embryogenesis and during carcinogenesis.
wNT4 wingless-type MMTv integration site family, 4; aliases: wNT-4, SERKAL; member of the wNT family of highly conserved, secreted 
signaling factors that regulate cell growth and differentiation; ligand for members of the frizzled family of seven transmembrane 
receptors; is likely to signal over only a few cell diameters; activates the canonical beta-catenin-mediated wnt pathway and binds 
Frizzled-6 receptor; wNT4 promoter harbors 2 p63/p73 response elements which contributes to an increase in wNT gene 
expression; wNT4 gene expression can be negatively regulated by Notch1 activation through p21wAF1/Cip1.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 6 Tumor suppressor genes
Gene and genomic locus  
(ensembl cytogenetic band)
Functions
CHD5 (1p36.31) Chromodomain helicase DNA binding protein 5; aliases: ATP-dependent helicase CHD5; belongs to a group  
of Swi/SNF proteins called CHD proteins, which contain a Swi/SNF-like helicase/ATPase domain, as well as a 
DNA-binding domain and a chromodomain that directly modifies chromatin structure; chromatin is maintained 
in a transcriptionally active state by CHD5 which can affect the expression levels of many genes at once and 
can affect the quick progression of a tumor; appears to be involved in early tumorigenic processes and controls 
proliferation, apoptosis, and senescence via the p16ink4a and p19Arf pathway; overexpression of CHD5 increases 
apoptosis through a p19Arf/p53 pathway; mice heterozygous for CHD5 are prone to spontaneous tumor formation; 
expression is downregulated through methylation, which may explain the higher level of colon cancer incidence in 
African Americans (78% with methylated CHD5) compared with iranians (47% with methylated CHD5).
DEAR1 (1p35.1) Ductal epithelium-associated RiNG chromosome 1; alias: TRiM62 (tripartite motif-containing 62); member 
of the RING-B-box-coiled-coil (RBCC)/TRIM subfamily of RING finger proteins which regulate tissue 
architecture; first member of the TRIM family that localizes to the cell–cell junction; down regulation in normal 
mammary epithelial cells results in formation of aberrant acinar structures with a loss of normal cell polarity 
and decreased rates of apoptosis.
APiTD1 (1p36.22) Apoptosis-inducing, TAF9-like domain 1; see Table 2 for general description; contains a predicted domain with 
similarity to the human TATA box-binding protein-associated factor, TAFII31, which is required for p53-
mediated transcriptional activation; since loss of function for APiTD1 is a mechanism by which tumor cells can 
overcome the cell growth-regulating and apoptosis-inducing properties of p53, it is considered to have tumor-
suppressive properties.
PRDM2 (1p36.21) PR domain containing 2, with ZNF domain; aliases: RIZ1, Zinc finger protein RIZ, HUMHOXY1, MTB-ZF, 
KMT8, retinoblastoma protein-interacting zinc finger protein, Lysine N-methyltransferase, MTE-binding 
protein, GATA-3-binding protein G3B, PR domain zinc finger protein 2; this tumor suppressor is a 
member of the nuclear histone/protein methyltransferase superfamily involved in chromatin-mediated gene 
expression; encodes a zinc finger protein that can bind to the retinoblastoma protein, estrogen receptor, 
and the macrophage-specific TPA-responsive element (MTE) of the heme oxygenase 1 (HO-1) gene; the PR 
domain is responsible for its tumor suppressing activity; the S-adenosyl-L-methionine-dependent histone 
methyltransferase activity of PRDM2 specifically methylates “Lys-9” of histone H3; regulates normal cell division 
and function using a “Yin-Yang” fashion; overexpression induces a G2-M cell cycle arrest and/or apoptosis (cell 
death independent of Rb and p53); expression and activity are reduced in many cancers; loss of activity results 
in decreased apoptosis and differentiation and enhanced proliferation; common target of frameshift mutation 
in microsatellite-unstable cancers; gene expression epigenetically silenced through promoter hypermethylation; 
upregulated by a methyl-balanced diet accompanied by the repression of the oncogene, c-jun.
SDHB (1p36.13) Succinate dehydrogenase complex, subunit B, iron sulfur (1p); SDH1, ip (iron-sulfur protein), GL4, succinic 
dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial; one of 4 nuclear-encoded subunits of 
complex II of the mitochondrial respiratory chain, specifically involved in the oxidation of succinate and 
the transfer of electrons from FADH to CoQ (ubiquinone); this iron-sulfur subunit is highly conserved and 
contains three cysteine-rich clusters which comprise the iron-sulfur centers of the enzyme; responsible for 
specifically transferring electrons from succinate to CoQ; decreased activity results in altered mitochondrial 
metabolism, the activation of pseudohypoxia and a shift to glycolytic respiration; SDHB-silenced cells can result 
in .400 genes either 6-fold or more upregulated or downregulated (dysregulated genes involve those involved 
in proliferation, adhesion, and the hypoxia pathway); DDHB-silenced cells display characteristic features of the 
tumor phenotype (eg, greater capacity to adhere to extracellular matrix components, including fibronectin and 
laminin) suggesting a possible mechanism of tumor initiation and enhanced tumorigenesis.
PRDX1 (1p34.1) Peroxiredoxin 1; see Table 7 for description; Prdx1 knockout mice generate malignancies in intestines, 
lymphomas, and sarcomas; prdx1−/− mouse cells show a shift in intracellular ROS from the cytoplasm to the 
nucleus with increased oxidative DNA damage; prdx1-deficient mouse cells show increased sensitivity to 
oxidative DNA damage; lower expression of PRDX1 found in tumors of the oral cavity and correlates with 
larger tumor size, lymph node metastasis, and clinically advanced stages. PRDX1 acts as a tumor suppressor in 
esophageal cells and induces apoptosis after activation by histone deacetylase inhibitors; interacts with a region of 
the c-Myc transcriptional regulatory (Myc box ii) domain that is essential for transformation, and selectively alters 
its biological function and target gene expression; inhibits c-Abl kinase activity by interacting with its SH3 domain.
PTCH2 (1p34.1) Patched homolog 2 (Drosophila); aliases: patched (Drosophila) homolog 2, PTC2, protein patched homolog 2; 
gene encodes a transmembrane receptor of the patched gene family; functions as a tumor suppressor by 
inhibiting another transmembrane protein SMO (smoothened), which functions in the hedgehog signaling 
pathway; receptor for Sonic Hedgehog, a secreted molecule implicated in the formation of embryonic 
structures and in tunorigenesis.
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Table 6 (Continued)
Gene and genomic locus  
(ensembl cytogenetic band)
Functions
CAMTA1 (1p36.31) Calmodulin binding transcription activator 1; cell cycle regulatory gene; in cases with 1p LOH, its expression is 
reduced by half, suggesting a functional effect caused by haploinsufficiency.
AJAP1 (1p36.32) Adherens junctions associated protein 1; aliases: SHREw1, Mot8, transmembrane protein SHREw1; membrane 
protein that targets to the basolateral membrane of polarized epithelial cells through cytoplasmic sorting motifs 
that include three tyrosines and a dileucine; interacts with E-cadherin-catenin complexes of adherens junctions; 
functions to inhibit cell adhesion and migration.
UBE4B (1p36.22) Ubiquitination factor E4B (UFD2 homolog, yeast); UBOX3, ubiquitin-fusion degradation protein 2, 
homozygously deleted in neuroblastoma-1; binds to the ubiquitin moieties of preformed conjugates and 
catalyzes ubiquitin chain assembly in conjunction with the E1, E2, and E3 classes of ubiquitin-activating enzymes; 
activity linked to cell survival under stress conditions; involved in protecting the cell from environmental stress; 
cleaved by caspase 6 and granzyme B during apoptosis.
NBL1 (1p36.13) Neuroblastoma, suppression of tumorigenicity 1; aliases: zinc finger protein DAN, DAND1, Dan domain family 
member, NO3; founding member of the evolutionarily conserved CAN (cerberus and DAN) family of proteins 
which contain a domain resembling the CTCK (C-terminal cystine knot-like) motif found in a number of signaling 
molecules; secreted protein which acts as BMP (bone morphogenetic protein) antagonist by binding BMPs and 
preventing them from interacting with their receptors; plays an important role in growth and development; 
contains a putative p53/p73-binding site in the 5′-upstream region of the gene; acts as an inhibitor of cell 
cycle progression; may play an important role in preventing cells from entering the final stage (G1/S) of the 
transformation process; functional association exists between NBL1 and p73 during cisplatin-induced cell death.
PLA2S-ii (1p36.13) The secretory type II phospholipase A2; aliases: MOM1 (modifier of MIN-1), group IIA phospholipase A2, non-
pancreatic secretory phospholipase A2, phosphatidylcholine 2-acylhydrolase 2A; catalyzes the hydrolysis of the 
sn-2 fatty acid acyl ester bond of phosphoglycerides, releasing free fatty acids and lysophospholipids, liberating 
arachidonic acid (AA) and prostaglandin D2, a metabolite of AA; participates in the regulation of phospholipid 
metabolism in biomembranes and the maintenance of membrane asymmetry; other known functions are 
related to microbial defense mechanisms (bactericidal activity) and the inflammatory response; human homolog 
of the MOM (modifier of min [APC]) gene, which suppresses polyp number during intestinal tumorigenesis in 
the min mouse model, possibly by altering the cellular microenvironment within the intestinal crypt or inducing 
AA metabolite-mediated apoptosis in pre-neoplastic or neoplastic cells.
ST7L (1p13.2) Suppression of tumorigenesis 7 like; aliases: related to the tumor suppressor gene, ST7, found at the 
chromosome 7q31 genomic locus; ST7L gene is clustered in a tail-to-tail manner with the WNT2B gene on 
chromosome 1p (analogous to the clustering of ST7 with the WNT2 gene on chromosome 7q; the related 
gene, ST7, induces changes in genes involving the re-modeling of the extracellular matrix, such as SPARC, 
IGFBP5 and several matrix metalloproteinases; may act as a tumor suppressor by modification of the tumor 
microenvironment.
RAD54L (1p34.1) RAD54-like (S. cerevisiae); see Table 1 and text for description.
E2F2 (1p36.12) E2F transcription factor 2; see Table 2 for description.
TNFRSF25 (1p36.31) Tumor necrosis factor receptor superfamily, member 25; see Table 3 for description.
PLK3 (1p34.1) Polo-like kinase 3; see Table 2 for description.
GADD45α (1p31.3) Growth arrest and DNA-damage-inducible 45 alpha; see Table 1 for description.
CTNNBiP1 (1p36.22) Alias iCAT; see Table 5 for description.
MUTYH (1p34.1) MutY homolog (E. coli); see Table 1 and text for description.
CDKN2C (1p32.3) Cyclin-dependent kinase inhibitor 2C; see Table 2 for description.
DFFA (1p36.22) DFFB (1p36.32) DNA fragmentation factor; see Table 3 and text for description.
KiF1B (1p36.22) Kinesin family member 1B; see Table 2 and text for description.
TP73 (1p36.32) Tumor protein 73; DNA damage response protein and pro-apoptotic tumor suppressor; see Table 1 and text 
for description.
MiR-34a (1p36.22) miRNA-34a; see Table 4 and text for description.
MiR-101-1 (1p31.3) miRNA-101-1; see Table 4 and text for description.
Excessive DNA ss breaks caused by the action of MUTYH 
and AP endonuclease in the nucleus results in the activation of 
PARP-1, which attaches polymers of ADP-ribose to proteins, 
thereby opening up the chromatin to allow access of DNA 
repair proteins.181,182 PARP initially serves as a survival protein 
facilitating the rapid repair of DNA strand breaks, and also 
prevents DNA degradation, in part, by inhibiting the   activity 
of deoxyribonucleases through the process of poly(ADP)
ribosylation.183 Since the synthesis of ADP-ribose polymers 
consumes nicotinamide adenine dinucleotide (NAD+),184 and 
NAD+ is largely found in mitochondria where it participates in 
the production of ATP (bottom right side of Figure 5), sustained Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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PARP activation will consume energy reserves, resulting in cell 
death, usually through the process of necrosis.185–188 A marked 
deficiency in energy reserves may cause the ATP-dependent 
Na+/K+ transport proteins, which maintain ionic balance, to 
fail, resulting in cell swelling and lysis of the cell,189 one of the 
hallmarks of necrosis.190
In addition to the above energy catastrophe caused by 
excessive PARP activity in the nucleus, persistent single-
stranded gaps in newly replicated DNA initiated by the action 
of MUTYH in mitochondria can result in the fragmentation and 
depletion of mitochondrial DNA (mtDNA)191,192 accompanied 
by the loss of mitochondrial function culminating in cell 
death191,193 (bottom right side of Figure 5). Dysfunctional 
mitochondria can release Ca++ into the cytosol which can 
activate calpains, causing Bax activation, lysosomal rupture, 
and the release of cathepsins into the cytosol191,194 resulting 
in a caspase-independent mode of cell death. Calpain 
activation can also result in Bax activation, followed by Bax 
oligomerization and mitochondrial damage, resulting in the 
loss of the mitochondrial membrane potential.
There is another unique mechanism that can lead 
to PARP-mediated cell death after excessive MUTYH 
activity, in addition to the fragmentation of mtDNA, 
energy catastrophe and calpain/lysosomal rupture/cathepsin 
pathways of mitochondrial failure described above. The main 
product of PARP-1 activity is the generation of polymers of 
ADP-ribose (PAR). Although these polymers are usually 
covalently bound to proteins, free PAR polymers are 
themselves toxic195–197 and function as a death signal.197–199 
The PAR polymers bind to mitochondria and induce the 
release of tAIF (truncated apoptosis-inducing factor) from the 
mitochondria into the cytosol199 (lower left side of Figure 5). 
tAIF is then translocated to the nucleus where it binds to 
DNA,200–202 causes DNA condensation203 and recruits DNA 
degrading factors (eg, endogenous endo- and exo-nucleases) 
resulting in DNA degradation198,204 (upper left side of 
Figure 5). This series of events is part of an intricate program 
of caspase-independent cell death,203–213 and is currently an 
active area of research.
Several mechanisms have been proposed to explain 
how tAIF is released from the mitochondria into the 
cytosol.210,214 Prior to truncation, AIF is embedded in the inner 
mitochondrial membrane,215 and the release of AIF requires 
its cleavage215,216 from a 62 kDa AIF mitochondrial form to 
a truncated 57 kDa soluble AIF form (tAIF).217,218 Calpain-I, 
which is activated by Ca++,219 and Ca++-independent cathepsins 
B, L, and S218,220 can cleave intramitochondrial AIF.221–223 
The calpains and cathepsins can truncate AIF in the same 
position at Gly102/Leu103.218 Calpain-I, however, appears 
to be the critical enzyme regulating AIF processing in which 
the AIF pathway is important for cell death.219 Oxidative 
modifcation of AIF markedly increases the susceptibility 
of AIF to calpain-I-mediated processing, most probably 
through the exposure of a normally hidden calpain cleavage 
site.219 Since the PAR polymer is a highly negatively charged 
molecule, it could depolarize mitochondria leading to opening 
of the mitochondrial membrane permeability transition pore 
(MPTP) followed by the release of tAIF.197,199 PAR polymers 
Table 7 Genes associated with antioxidant function
Gene Protein function
GCLM Glutamate-cysteine ligase, modifier subunit; aliases: gamma-glutamylcysteine synthetase, GSC light chain; the first rate limiting 
enzyme of glutathione synthesis; the enzyme consists of a heavy catalytic subunit and a light (30.8 kDa) regulatory subunit.
GPX7 Glutathione peroxidase 7; non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase; alleviates oxidative 
stress generated from polyunsaturated fatty acids.
PRDX1 Peroxiredoxin 1; aliases: thioredoxin peroxidase 2, thioredoxin-dependent peroxide reductase 2, TDPX2, natural killer cell-
enhancing factor A, PAG, PAGB; member of the peroxiredoxin family of antioxidant enzymes which reduce hydrogen peroxide 
and alkyl hydroperoxides; the enzyme reduces peroxides using reducing equivalents provided through the thioredoxin system, not 
through glutaredoxin; plays an important role in eliminating peroxides generated during metabolism; participates in the signaling 
pathways of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of hydrogen peroxide; 
overoxidized peroxiredoxins (eg, cysteines oxidized to cysteine sulfinic or sulfonic acids) are regenerated by p53-regulated 
sestrins (homologs of a bacterial AhpC which reduces bacterial peroxiredoxins), thus re-establishing the antioxidant firewall.
TXNDC12 Thioredoxin domain containing 12; aliases: endoplasmic reticulum protein ERP19, ERP19, hTLP19, protein disulfide isomerase 
family A (member 16), endoplasmic reticulum thioredoxin superfamily member, 18 kDa; members of this superfamily possess 
a thioredoxin fold with a consensus active-site sequence (CxxC) and have roles in redox regulation, defense against oxidative 
stress, refolding of disulfide-containing proteins, and regulation of transcription factors; induced at the transcriptional level by 
the unfolded protein response (UPR), a signaling pathway that responds to the accumulation of misfolded proteins; possesses 
significant protein thiol-disulfide oxidase activity; inhibits the induction of apoptosis by agents that cause ER stress, including 
brefeldin A, tunicamycin, and dithiothreitol; smallest member of the protein disulfide isomerase (PDI) family of proteins to contain 
a Cys-Xxx-Xxx-Cys active site motif; like the catalytic domains of PDis; TXNDC12 adopts a thioredoxin fold with a thioredoxin-
like active site located at the N-terminus of a long kinked helix that spans the length of the protein.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 8 Genes associated with protection against environmental and metabolic toxicity
Gene Protein function
AADACL3 Arylacetamide deacetylase-like 3; the enzymatic activity of the family of arylacetamide deacetylases carry out 
the deacetylation of carcinogenic arylacetamides such as 4-acetylaminobiphenyl, 2-acetylaminofluorene, and 
2-acetylaminaphthalene.
AADACL4 Arylacetamide deacetylase-like 4; the enzymatic activity of the family of arylacetamide deacetylases carry out 
the deacetylation of carcinogenic arylacetamides such as 4-acetylaminobiphenyl, 2-acetylaminofluorene, and 
2-acetylaminaphthalene.
AKR1A1 Aldo-keto reductase family 1, member A1; aliases ALDR1, ARM, dihydrodiol dehydrogenase 3; member of the aldo/
keto reductase superfamily; catalyzes the NADPH-dependent reduction of a variety of biogenic/xenobiotic aromatic and 
aliphatic aldehydes to their corresponding alcohols; oxidizes proximate carcinogen trans-dihydrodiols to o-quinones.
AKR7A2 Aldo-keto reductase family 7, member A2; aliases: succinic semialdehyde reductase, SSA reductase, AFAR1; catalyzes 
the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate; can reduce the dialdehyde 
protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol.
AKR7A3 Aldo-keto reductase family 7, member A3; aliases: AFAR2, AFB1 aldehyde reductase 2; involved in the detoxification  
of aldehydes and ketones; can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding 
AFB1 dialcohol.
AKR7L Aldo-keto reductase family 7-like; aliases: AFAR3, AFB1 aldehyde reductase 3; involved in the detoxification of 
aldehydes and ketones; can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding  
AFB1 dialcohol; this family member encodes a selenoprotein, which contains a selenocysteine residue; the 
selenocysteine is encoded by the UGA codon that normally signals translational termination.
CYP2J2 Cytochrome P450, family 2, subfamily J, polypeptide 2; aliases: microsomal monooxygenase, flavoprotein-linked 
monooxygenase, arachidonic acid epoxygenase; the cytochrome P450 superfamily of enzymes catalyze many reactions 
involved in drug metabolism and synthesis of cholesterol, steroids and other lipids; this protein localizes to the 
endoplasmic reticulum and is the predominant enzyme responsible for epoxidation of endogenous arachidonic 
acid pools in cardiac tissue; also functions in the gastrointestinal tract; epoxygenase-derived eicosanoids have anti-
inflammatory properties.
CYP4Z1 Cytochrome P450, family 4, subfamily Z, polypeptide 1; catalyzes the in-chain hydroxylation of lauric acid and myristic 
acid; single-pass type ii membrane protein found in the endoplasmic reticulum.
CYP4A11 Cytochrome P450, family 4, subfamily A, polypeptide 11; aliases: fatty acid omega-hydrolase, lauric acid omega-
hydrolase, alkane-1 monooxygenase, 20-hydroxyeicosatetraenoic acid synthase; this CYP450 member localizes  
to the endoplasmic reticulum and catalyzes the omega- and omega-1-hydroxylation of medium-chain fatty acids  
such as laurate, myristate and palmitate; oxidizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).
CYP4A22 Cytochrome P450, family 4, subfamily A, polypeptide 22; aliases: fatty acid omega-hydroxylase, lauric acid omega-
hydrolase; this CYP450 member localizes to the endoplasmic reticulum and catalyzes the omega- and (omega-1)-
hydroxylation of medium-chain fatty acids such as laurate and palmitate; shows no activity toward arachidonic acid  
and prostaglandin A1.
CYP4B1 Cytochrome P450, family 4, subfamily B, polypeptide 1; aliases: microsomal monooxygenase, P-450HP; this enzyme  
is located in the endoplasmic reticulum and oxidizes a variety of structurally unrelated compounds, including steroids, 
fatty acids and xenobiotics; involved in an NADPH-dependent electron transport pathway; can be induced to high levels 
in the liver and other tissues by various foreign compounds, including drugs, pesticides, and carcinogens.
CYP4X1 Cytochrome P450, family 4, subfamily X, polypeptide 1; aliases: CYPivX1, MGC40051; located in the endoplasmic 
reticulum and may be involved in neurovascular function in the brain.
GSTM1 Glutathione S-transferase Mu 1; aliases: glutathione S-alkyltransferase M1, S-(hydroxyalkyl)glutathione lyase M1,  
HB subunit 4; glutathione transferases may serve as an antioxidant system preventing degenerative cellular processes; 
the genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known 
to be highly polymorphic; this enzyme conjugates glutathione to a wide number of endogenous and exogenous toxins 
and carcinogens; null mutations of class mu genes have been linked with an increase in a number of cancers, most likely 
caused by an increased susceptibility to environmental toxins and carcinogens; specific genetic polymorphisms are 
associated with susceptibility to colorectal cancer.
GSTM2 Glutathione S-transferase Mu 2; aliases: glutathione S-alkyltransferase M2, S-(hydroxyalkyl)glutathione lyase M2; this 
enzyme conjugates glutathione to a wide number of endogenous and exogenous toxins and carcinogens; alleviates 
benzo[a]pyrene-diolepoxide-DNA damage.
GSTM3 Glutathione S-transferase Mu 3; aliases: glutathione S-alkyltransferase M3, S-(hydroxyalkyl)glutathione lyase M3; this 
enzyme conjugates glutathione to a wide number of endogenous and exogenous toxins and carcinogens; GSTM1 and 
GSTM3 allele variants are a risk-modulating factor in colorectal cancer patients.
GSTM4 Glutathione S-transferase Mu 4; aliases: glutathione S-alkyltransferase M4, S-(hydroxyalkyl)glutathione lyase M4; this 
enzyme conjugates glutathione to a wide number of endogenous and exogenous toxins and carcinogens; active on 
1-chloro-2,4-dinitrobenzene.
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of increasing complexity and molecular weight are more 
toxic than simple PAR polymers of low molecular weight.197 
The PAR polymer could also bind to PAR polymer binding 
proteins associated with mitochondria, which then release 
AIF.199,224–226 This results in AIF cleavage producing a tAIF, 
which is soluble and enters the cytosol. The release of 
tAIF may also be caused by a significant but not excessive 
decrease in NAD+ (as a result of PARP activity), ATP, and 
the mitochondrial membrane potential, resulting in the 
opening of the MPTP (mitochondrial permeability transition 
pore).186,196,211 The release of tAIF may also be caused by other 
caspase-independent pathways involving molecules that are 
often found in the downstream execution phase of apoptosis, 
such as tBid (truncated Bid),227–229 Bax oligomers (formed after 
Table 8 (Continued)
Gene Protein function
GSTM5 Glutathione S-transferase Mu 5; aliases: glutathione S-alkyltransferase M5, S-(hydroxyalkyl)glutathione lyase M5; this 
enzyme conjugates glutathione to a wide number of endogenous and exogenous toxins and carcinogens.
MTF1 Metal response element binding transcription factor 1; transcription factor that induces the expression of 
metallothioneins and other genes involved in metal homeostasis in response to heavy metals such as cadmium, zinc, 
copper and silver; is a nucleocytoplasmic shuttling protein that accumulates in the nucleus upon heavy metal exposure 
and binds to promoters containing a metal-responsive element; nucleocytoplasmic shuttling of MTF1 is regulated by 
diverse signals.
MTF2 Metal response element binding transcription factor 2; alias: polycomb-like protein 2; binds to the metal-regulating 
element of the metallothionein-1A gene promoter, which is zinc-dependent.
Inflammation, Dietary factors
Spindle damage
Repair of DNA damage and
mitotic disturbances
Mitotic progression of cells with
undamaged DNA and proper
segregation of daughter chromosomes
Normal cell
Dysfunctional
telomeres
Spindle assembly
checkpoints
DNA damage
checkpoints
Cell cycle arrest
DNA damage
ROS/RNS
Figure 1 The damaging effects of dietary factors and inflammatory conditions on 
the colonic epithelium. Damage to DNA, the mitotic spindle, and to telomeres is 
mediated through the generation of ROS (reactive oxygen species) and/or RNS 
(reactive nitrogen species). This damage results in the activation of spindle and DNA 
damage checkpoints, which delay mitosis until repairs are made.
Inflammation, Dietary factors
Prolonged cell cycle arrest
Cancer
Cell death
Excessive
spindle damage
Marked dysfunctional
telomeres
Genomic instability
(proliferating cells)
Excessive
DNA damage
ROS/RNS
Figure 2 Excessive spindle damage, dysfunctional telomeres, or DNA damage can 
result in a prolonged cell cycle arrest which activates pro-cell death pathways. This 
activation of pro-cell death pathways leads to removal of cells with unrepaired 
damage to the mitotic spindle, the chromosome ends, and DNA and prevents the 
potential propagation of cells with many types of genomic instability. 
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activation of Bax by Ca++-dependent calpains),211,217 Bak,230 
and Bim-EL.231,232 The activation of PARP also activates 
other stress-response pathways such as the RIP/TRAF2/
JNK pathway,233–235 which may be responsible, in part, for 
generation of tBid228 and the phosphorylation of Bim-EL. 
The phosphorylation of Bim-EL releases Bim-EL from 
sequestration by the microtubular dynein motor complex,236 
allowing it to bind to bcl-2,231 thereby enhancing the cell 
death process.
Mechanisms that interfere with tAIF release include 
the 1) degradation of the PAR polymer by PARG (PAR 
glycohydrolase),237 2) inhibition of tAIF translocation to the 
nucleus by Bcl-2, Bcl-xl, HSP70, or Iduna, and 3) interfer-
ence of transcription of the AIF gene by BNIP3.238 PARG, 
Bcl-2, Bcl-xl, HSP70, Iduna, and BNIP3 have been shown 
to be upregulated during carcinogenesis, consistent with the 
development of tumor cell resistance to cell death. In addition, 
pro-cell death molecules involved in this MUTYH/PARP/
AIF pathway, such as AIF, Bid, Bax, Bak, and Bim-EL, have 
been reported to be downregulated during carcinogenesis. 
Thus, overall, MUTYH likely has an important role in the 
death of cells exposed to excessive reactive oxygen species/
reactive nitrogen species (ROS/RNS)-induced DNA   damage, 
and interference with the MUTYH cell death pathway is 
associated with carcinogenesis.
P73 and caspase-dependent cell death
Like p53, p73 is responsible for the induction of apop-
tosis in response to excessive DNA damage that   cannot 
be repaired.239 P73 has the ability to upregulate the tran-
scription of numerous classic apoptosis-related genes 
such as caspases 3, 6, and 8, Bcl-2 family members, and 
death receptors (Figure 6). In order for p73 to function 
as a transcription factor, it must be   phosphorylated. The 
c-Abl kinase, activated by DNA damage, phosphorylates 
and activates p73 on tyrosine 99.240 The stress-induced 
  mitogen-activated protein kinase, p38 MAPK, phospho-
rylates and activates p73 on threonine residues.239 The 
degradation of p73 by the E3 ubiquitin-like protein, Itch, is 
prevented by the   Yes-associated   protein, YAP. E2F1, p53, 
and c-jun (located on chromosome 1p;   Figures 4 and 6) may 
also have a role in p73 activation in   different cell types.241,242 
One mechanism by which p73 induces apoptosis includes 
the transcription of PUMA (p53 upregulated   modulator 
of apoptosis), which in turn causes Bax translocation to 
the mitochondria with the release of   cytochrome c.243 
A   second mechanism involves the transcription of scotin, 
which causes endoplasmic reticulum (ER) stress and sub-
sequent apoptosis.244,245 Unlike p53, a direct role of p73 in 
the apoptotic process (eg, mitochondrial translocation and 
  perturbation) has not been verified. The role of p73 in the 
regulation of the miRNA processing complex will be dis-
cussed in the   section “MiRNAs and miRNA   processing”. 
As noted above, loss of p73 through chromosome 1p dele-
tion occurs early in colon carcinogenesis, contrary to the 
loss of p53 which is a late event.
Mitosis-related and spindle checkpoint 
function (Table 2)
There are 24 genes on chromosome 1p whose gene products 
affect many different aspects of the mitotic process, and 
include kinases, phosphatases, centromere proteins, cen-
trosome proteins, cyclins, regulatory mitotic proteins, motor 
spindle proteins, regulators of chromosomal condensation, 
a mitosis-related transcription factor, a deacetylase, and 
a major spindle checkpoint protein (Table 2). The large 
number of mitosis-related genes that are lost if there is a 
chromosome 1p deletion could potentially be responsible 
for colon cancer initiation and progression, since cancer 
epidemiology studies show that abnormal expression 
of mitosis-related genes is frequent in different tumor 
types.246,247 Mitotic checkpoints, and specifically the spindle 
assembly checkpoint, are major targets for tumor-associated 
alterations.247 The mitotic spindle assembly checkpoint is 
essential for ensuring that all   chromosomes are properly 
aligned on the metaphase plate, with every chromosome 
AB
C D
Figure 3 Examples of cellular alterations that accompany apoptosis (A), mitotic 
perturbation during anaphase (B), mitotic catastrophe with complete chromosome/
spindle  disruption  (C),  and  abundant  micronuclei  formation  associated  with 
aneuploidy (D). Panels A, B, and D are examples of HCT-116 cells treated with 
10 µM camptothecin. Panel C represents cells treated with 5 µM phenstatin (drug 
obtained through courtesy of Dr GR. Pettit, Arizona State University) (cytospin 
preparations of Giemsa-stained cells; ×100 oil objective lens)Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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attached to a spindle microtubule by its kinetochore to 
prevent aneuploidy.97 If these processes fail to occur and 
the cell undergoes a prolonged mitotic arrest (Figure 2), 
the cell may be eliminated through caspase-dependent or 
caspase-independent cell death mechanisms147 to ensure 
genomic stability (Figure 7).
Oxidative stress is a major factor that can induce 
  disturbances in spindle organization,248,249 induce centrosome 
amplification, cause proteolysis of the anaphase inhibitor 
securin and mitotic cyclins,250 affect components of the 
anaphase-promoting complex,251 and override the spindle 
checkpoint,250 thereby affecting chromosomal stability. 
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Figure 4 DNA damage causes several downstream molecular and cellular events. The DNA damage response involves several DNA repair proteins and transcription factors 
that allow the cell cycle to be arrested at several points to enhance genomic stability. All of the genes associated with these damage response pathways that are also found 
on chromosome 1p are highlighted in red, and reference to the appropriate tables (contain functions of gene products) in the text is provided below. The large number of 
molecular and cellular events affected by the loss of chromosome 1p is apparent. 
Notes: Genes: CLSN, DCLRE (APOLLO), GADD45α, MSH4, MUTYH, TP73, RAD54L (Table 1); CDC7 (phosphorylates claspin in response to DNA damage), PSRC1 
(DDA3) (Table 2); NBL1 (Table 6). Additional protein functions in diagram not discussed in text: astrin (microtubule binding protein involved in the functional and dynamic 
regulation of mitotic spindles); CHK1 (checkpoint homolog of S. pombe; serine/threonine-protein kinase required for cell cycle arrest in response to DNA damage or 
presence of unreplicated DNA); cyclin B1 [regulatory protein involved in mitosis; complexes with p34 (cdc2) to form the maturation-promoting factor, MPF; expressed 
predominantly during G2/M]; TP53iNP1 (tumor protein p53-inducible nuclear protein 1; in response to DNA damage, it promotes p53 phosphorylation on “Ser-46” and 
promotes cell cycle arrest; promotes apoptosis if DNA damage is excessive); TRF2 (telomeric repeat binding factor 2; component of the shelterin complex that binds the 
telomere double-stranded – TTAGGG – repeat and protects telomere ends). 
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During the process of mitosis, direct oxidative damage to 
chromosomes resulting in double-strand breaks, or oxidative 
damage to telomeres can activate p53 (Figure 7) or p73 
(Figure 6), major DNA damage response proteins that elicit 
apoptosis through multiple caspase-dependent mechanisms. 
In addition, caspase-independent mitotic cell death can also 
occur during a mitotic catastrophe (Figure 3C, Figure 7), 
which is a prestage to distinct modes of cell death that may 
be caspase-dependent or caspase-independent.148
The length of time that a spindle is destabilized may 
determine the mode and timing of cell death after mitotic 
exit.123,124,126 It has been suggested that prolonged mitotic 
ROS/RNS
tAIF
tAIF
PAR
Cell death
MUTYH
Cystosine
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Figure 5 The mechanisms by which excessive activity of MUTYH and AP endonucleases can lead to cell death through the activation of PARP and the generation of toxic 
poly(ADP)ribose (PAR) polymers and mitochondrial DNA (mtDNA) damage (see text for detailed description). 
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delay can lead to the decay of anti-apoptotic messenger 
RNAs (mRNAs)252,253 and/or the gradual accumulation of 
pro-apoptotic signals.252,254 Of the 24 mitosis-related genes 
(Table 2), the products of 7 genes have dual-role mitosis/
pro-apoptotic functions. These dual-role mitosis/pro-apoptotic 
genes include APITD1, CCNL2, CDC2L2, CDC42, E2F2, 
KIF1B, and PLK3 (Table 2). Cells may become genomically 
unstable if they evade mitotic checkpoints through a process 
referred to as mitotic slippage, mitotic arrest slippage, or 
mitotic checkpoint slippage255–263 (Figure 7). With mitotic 
slippage, the cell exits mitosis prematurely, carrying broken 
chromosomes, abnormal numbers of chromosomes, and 
unrepaired DNA damage into the daughter cells. In addition 
to loss of pro-apoptotic proteins, it has been reported 
that the gradual loss of the checkpoint effector, cyclin B, 
releases the mitotic arrest induced by spindle disruptive 
agents, despite the continued presence of spindle damage 
and upstream checkpoint proteins.14,258,260 In order for a 
DNA-damaged cell to survive after mitotic slippage, it must 
evade both apoptosis in the subsequent G1 phase of the cell 
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Figure 6 The possible mechanisms by which p73 transcription and activation can lead to cell death through classic apoptotic mechanisms. Definitions of proteins not included 
in the main text: PERP (p53 apoptosis effector related to PMP22; tetraspan membrane protein and component of intercellular desmosome junctions); p53AiPi (p53 apoptosis-
inducing protein 1; promoter activated by acetylated p73); FAS (CD95) (member 6 of the TNF receptor superfamily which contains a death domain); TNFR1 (member 1A 
of the TNF receptor superfamily); TRAiL-R1 (member 10A of the TNF receptor superfamily); TRAiL-R2 (member 10B of the TNF receptor superfamily; death receptor 5); 
PIG3 (p53-induced gene 3 protein; quinone oxidoreductase involved in the generation of ROS and cell death). 
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cycle124 (Figure 7) and reproductive cell death that can follow 
centrosome amplification and the generation of tetraploid 
cells264 (Figure 7).
Thus, a decrease in pro-apoptotic mitotic/cell cycle-
related genes located on chromosome 1p (APITD1, CCNL2, 
CDC2L2, CDC42, E2F2, KIF1B, PLK3) (Table 2) may 
result in resistance to cell death, a critical event that drives 
tumorigenesis.52,54,265–267
Apoptosis-related genes (Table 3)
Seven genes associated with apoptosis are located on 
  chromosome 1p. Bcl-10 and Bcl2L15 are Bcl-2 family 
members, THAP3 is a zinc-coordinating DNA-binding 
protein, DNA fragmentation factor A (DFFA) and B (DFFB) 
are the two subunits of DFF, caspase-9 is a major initiator 
caspase in the apoptotic proteolytic cascade, and TNFRSF25 
is a death domain-containing receptor related to TNFR-1 and 
CD95 (Apo-1/Fas). The deletion of 3 of these genes would 
have important implications for carcinogenesis through the 
increase in apoptosis resistance, and will be discussed in 
some detail.
DFF is a heterodimeric protein composed of a catalyti-
cally active 40 kD subunit, DFFB (CAD [caspase-activated 
DNase]), and an inhibitory 45 kD subunit, DFFA (ICAD 
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Figure 7 The different cellular fate following spindle, telomere and DNA damage during mitosis. Cells with excessive genomic damage can undergo caspase-dependent cell 
death (CDMCD) or caspase-independent mitotic cell death (CiMCD). DNA-damaged cells may, however, exit from mitosis by defying cell death pathways through a process 
referred to as mitotic slippage. These preneoplastic cells with DNA damage and chromosomal abnormalities can then be clonally expanded to produce a tumor and eventually 
develop into a malignancy through continued cycles of damage to the genome. 
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[inhibitor of CAD]).268,269 When bound to DFFB, DFFA 
inhibits the nuclease activity of DFFB.268,269 During apop-
tosis, caspase-3 cleaves DFFA at amino acids 117 and 
224 and dissociates it from DFFB, thereby releasing the 
inhibition of DFFB.270 DFFB activity results in chromatin 
condensation271 and the formation of the typical crescents 
and margination of chromatin that are characteristic of 
classic apoptotic cells at the ultrastructural level.190,266,272–276 
Characteristic ultrastructural features of apoptotic cells 
treated with a ROS-generating and DNA-damaging agent 
are shown in Figure 8. At the molecular level, the action 
of DFF on DNA results in the initial cleavage of DNA 
into 50- to 300-kb long fragments,277,278 representing the 
dismemberment of the higher order organization of chroma-
tin into chromosomal loop domains, and the fragmentation 
of DNA into oligonucleosomal sized fragments that form a 
“ladder” on agarose gel electrophoresis.279 The importance 
of DFF in suppressing tumorigenesis280 was demonstrated 
by Yan et al281 using DFF40-null mice. DFF-deficient cells 
exhibit significant increases in mutation, chromosomal 
instability, and survival compared with wild-type control 
cells.281 This is probably a result of the inhibition of cell 
death of DNA-damaged cells resulting from the failure to 
undergo DNA fragmentation.282,283 DFF is reported to avoid 
chromosome instability in a p53-independent manner.284 
Irradiation of cells with a caspase-resistant form of DFFA 
led to increased clonogenic survival of cells with increased 
chromosomal aberrations and aneuploidy.284 The ability of 
DFF to maintain chromsosomal stability appears to be the 
result of the DNA fragmentation-induced death of cells with 
excessive DNA damage.284 Although DFFB has intrinsic 
DNAse activity, both DFFA and DFFB are required to gener-
ate DNase activity,140,269 and must be co-expressed.280 DFFA 
has been postulated to stabilize the synthesis of DFFB,270,271 
or mediate the correct folding and chromatin localization 
of DFFB.271 The absence of DFF results in an increased 
frequency of cell transformation and enhanced susceptibil-
ity to radiation-induced carcinogenesis, indicating that DFF 
is a tumor suppressor.280 Recently, it has been reported that 
the expression of DFFA protein, but not DFFA mRNA, 
is regulated by a specific miRNA, miR-145, suggesting a 
mechanism of translational regulation.285 The regulation of 
DFFB by miRNA has not been investigated, and, so far, none 
of the miRNAs found on chromosome 1p (Table 4) have 
been determined to have DFFA or DFFB as target mRNAs 
for translational regulation.
Caspase-9 is a member of the family of cysteine-aspartic 
acid-specific proteases (caspases), and is also referred to as 
Apaf-3 (apoptotic protease-activating factor 3). In the presence 
of cytochrome c and dATP, Apaf-1 binds to procaspase-9286 
via a CARD (caspase activation recruitment domain),287 
forming a complex referred to as the apoptosome.286,288,289 
The cellular oxidative state can affect apoptosome formation 
by promoting an interaction between caspase-9 and Apaf-1 
via disulfide formation.290 In the apoptosome, caspase-9 is 
activated to process other downstream caspases, including 
caspase-3 and caspase-2.291 Caspase-9 plays an important role 
in apoptosis induced by genotoxic stress.292,293 The caspase-
9-induced apoptotic pathway can result from mitochondrial 
membrane depolarization, formation of the apoptosome, 
A
B
Figure  8  Transmission  electron  micrographs  of  HCT-116  cells  reacted  with 
0.5 mM sodium deoxycholate for 2 hours. A) Normal cell (arrow 1) with prominent 
nucleolus and dispersed chromatin; arrow 2 points to a cell in early apoptosis, 
showing margination of chromatin, a nucleolus showing nucleolar segregation, and 
an increase in electron density compared with the normal cell; arrow 3 points to a 
cell in a late stage of apoptosis showing condensed chromatin, a marked increase 
in electron density compared with the cell above, and apoptotic body formation.   
B) Apoptotic cell in a late stage of apoptosis showing condensed chromatin (including 
crescent formation), an increase in electron density, and cytoplasmic vacuole (v) 
formation. (Uranyl acetate, lead citrate stains.)Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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and the activation of multiple caspases, including caspase-3 
and caspase-2.294 Loss of caspase-9 is therefore important 
to carcinogenesis, since it can result in apoptosis resistance 
and the propagation of DNA-damaged cells.295 If caspase-9 
is lost, caspase-3 cannot be activated, and thus cannot cleave 
many substrates including DFFA, an essential endonuclease 
in apoptosis (see previous page). Similarly, if caspase-9 
is lost, caspase-2 may not be activated. Caspase-2 plays a 
specific role in genotoxic stress-induced apoptosis in some 
cell types.296,297 (However, there is another pathway for 
activation of caspase-2. Activation of p53 by DNA damage 
can result in the p53-mediated transcription of the death 
domain protein PIDD [p53-induced protein with a death 
domain], which, together with RAIDD or RIP1, can form 
a multiprotein complex called the PIDDosome298–300 which 
then activates caspase-2298). DNA damage can also activate 
caspase-2 through the activation of c-Abl.301 C-Abl binds 
directly to caspase-9, phosphorylates it on Tyr-153, which 
then results in the autocleavage and activation of caspase-9 
resulting in the apoptosis of excessively DNA-damaged 
cells.301 Caspase-9 also mediates apoptosis caused by ER 
stress.302 ER stress first activates caspase-12,302 which is 
located on the outer membrane of the ER;303 caspase 12 then 
activates caspase-9 through a cytochrome c-independent 
mechanism.302 In some cells, ER stress can result in caspase-8 
activation, formation of tBid, mitochondrial damage, release 
of cytochrome c and the activation of caspase-9 through the 
formation of the apoptosome.304 Therefore, ER stress can 
activate caspase-9 through both mitochondrial-independent 
and -dependent mechanisms.
MiRNAs and miRNA processing (Table 4)
miRNAs are evolutionarily conserved, endogenous, small 
(21 to 24 nucleotides) non-coding RNAs cleaved from 70 
to 100 nucleotide hairpin-shaped precursors that reduce 
translation and stability of target mRNAs through RISC 
(RNA interference effector complex)-mediated mRNA 
degradation and translational suppression via sequence-
recognition interactions with the 3′ untranslated region of 
their targeted mRNAs.305–315 The diverse cellular functions 
affected by miRNAs306,316,317 is underscored by the prediction 
that thousands of genes are potential miRNA targets.318–320 
At least 800 different miRNAs predicted by computational 
scanning in the human genome have been documented 
(http://microrna.sanger.ac.uk). Individual miRNAs have the 
potential to downregulate large numbers of target mRNAs 
with seed region complementary sites in their 3′ untrans-
lated regions.321–323 It has been speculated that miRNAs 
could regulate ∼30% of the human genome.306 MiRNAs 
function in proliferation, cell cycle control, the prevention of 
replicative stress, differentiation, and apoptosis.324–333 More 
than half of the known human miRNAs are located at fragile 
sites, as well as at sites of LOH, amplification, and common 
breakpoint regions, which are particular genomic regions that 
are prone to alteration in cancer cells.327 The overexpression 
or underexpression of miRNAs as a result of chromosomal 
additions or deletions, respectively, in individual cells can 
have dramatic effect on hundreds to thousands of target 
genes. It is, therefore, not surprising that aberrant expression 
of miRNAs is associated with cancerous tissues,334–340 and 
that characteristic miRNA expression profiles are features 
of certain human cancers.341–350 Impaired miRNA processing 
enhances cellular transformation and tumorigenesis,351,352 and 
certain miRNAs are even classified as tumor suppressors and 
oncogenes.353–355 Alterations in a series of specific miRNAs 
have been associated with the age of onset of colon cancer, 
the growth of colon cancer cells, and certain stages of colon 
carcinogenesis.344,356–369 Human colon cancer profiles from 
80 colon tumors and 28 samples of normal mucosa show 
differential miRNA expression depending on mismatch 
repair status and are characteristic of undifferentiated 
proliferative states.367 Examination of the genomic regions 
containing differentially expressed miRNAs revealed that 
they were also differentially methylated in colon cancer at a 
far greater rate than would be expected by chance.367 MiRNA 
profiles could accurately predict microsatellite status in a set 
of 39 colon cancer studied by Lanza and colleagues.370 This 
is probably a reflection of the presence or near absence of 
chromosomal instabilty in the respective microsatellite stable 
vs unstable cancers.371
There are 20 miRNAs and 3 components of the miRNA 
processing complex (Argonaute proteins 1,3,4) encoded on 
chromosome 1p (Table 4). One of the 20 miRNAs,   miR-34a, 
is known to be regulated by p53.309,330,372–376 Tarasov et al375 
evaluated the differential regulation of 74 miRNAs by p53; 
50 miRNAs were either positively or negatively regulated by 
p53, miR-34a showing the highest fold increase (33.4 fold). 
Although the 20 miRNAs found on chromosome 1p can have 
pleiotropic effects on cells, miR-34a is the most well studied 
for its role in cell cycle arrest and apoptosis in response to 
DNA damage.309,330,374,377,378 The miR-34 family of miRNAs 
is one of only 18 mammalian miRNA families379 that are 
present in flies and worms.309 It is probable that links between 
p53 and the miRNA-34 family may have arisen early in the 
evolution of the stress-related p53 network.309 Because of its 
central role in preventing carcinogenesis, miR-34a has been Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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classified as a tumor suppressor.372,377 MiR-34a has numerous 
  downstream targets, including bcl-2 (major anti-apoptotic 
protein), NOTCH1, Delta1 (ligand for NOTCH1), NOTCH2 
(found on chromosome 1p), CDK4, CDK6, Cyclin D1, Cyclin 
E2, c-Met, MYCN, SIRT1 and E2F3.319,362,374,375,377,380–384 The 
inhibition of NOTCH1 by miR-34a would enhance apoptosis 
since NOTCH1 is known to inhibit p53 activity385,386 and 
to have an anti-apoptotic role387,388 in tumorigenesis. The 
inhibition of SIRT1 by miR-34a contributes to p53-dependent 
apoptosis389 through deacetylating and stabilizing p53 leading 
to an increase in p21 and PUMA.384 The E2F3 transcription 
factor is not known to have a role in apoptosis; however, 
it is a novel repressor of the ARF/p53 pathway390 and a 
potent transcriptional inducer of cell-cycle progression.377 
Therefore, the downregulation of E2F3 by miRNA-34a 
would have a growth inhibitory effect.362,374 MYCN has 
important roles in both cell proliferation and apoptosis, and 
MYCN amplification is almost always associated with the 
loss of chromosome 1p36.382 It is probable that the effects of 
miR-34a on cellular molecular pathways is widespread, since 
enforced expression of 34A shows a   dramatically altered 
gene expression profile with upregulation of 532 mRNA 
transcripts and downregulation of 681 mRNA transcripts 
highly enriched for those genes that regulate cell-cycle pro-
gression, apoptosis (BCL2, BIRC3 [baculoviral IAP repeat-
containing 3], DcR3 [decoy receptor 3]), DNA repair, and 
  angiogenesis.330 In   conclusion, although p53 is a late event 
in colon   carcinogenesis, the deletion of a major downstream 
target of p53, miR-34a, as a result of chromosomal 1p dele-
tion, could have dramatic effects on colon tumorigenesis.
MiR-101 is a miRNA that, like 34a, is pro-apoptotic391 and 
considered to be a tumor suppressor.391,392 The nomenclature 
of miR-101-1 (Table 4) and miR-101-2 is based on the 
fact that miR-101-1 is produced from a genomic locus on 
chromosome 1p31 and miR-101-2 from a genomic locus on 
chromosome 9p24.392 Loss of heterozygosity at both 1p and 
9p are known to be associated with cancer.392 The mechanism 
by which miR-101 induces apoptosis is by targeting and 
decreasing the expression of the multifaceted anti-apoptotic 
protein Mcl-1 (myeloid cell leukemia sequence 1).391 Mcl-1 
undergoes rapid turnover which may serve as a convergence 
point for signals that affect global translation, thereby 
coupling translation to cell survival and the apoptotic 
machinery.393 (The DNA damage response can also result 
in Mcl-1 destruction and the initiation of apoptosis.394,395) 
Mcl-1 specifically inhibits apoptosis, in part, by sequestering 
the pro-apoptotic Bim, Bak, tBid, and Noxa, in an inactive 
state. Since Mcl-1 can interact with tBid and inhibit its 
induction of cytochrome c release, it plays an important role 
in resistance to TRAIL and TNFα-induced apoptosis.396,397 
Therefore, Mcl-1 can inhibit apoptosis induced by both 
the death receptor (extrinsic) and mitochondrial (intrinsic) 
pathways. Mcl-1 is targeted for proteasome-mediated 
degradation by the E3 ubiquitin ligase MULE398 and is rapidly 
degraded with a half-life of 30 minutes to 3 hours.393 Its short 
half-life relates to the presence of a long proline-, glutamic 
acid-, serine-, and threonine-rich (PEST) region upstream of 
the Bcl-2 homology domains.398 The inhibition of translation 
with cycloheximide can cause the rapid degradation of 
Mcl-1 within 30 minutes, thereby triggering the apoptotic 
machinery through the release of Bim and the activation 
of Bak and Bax.393 Although full-length Mcl-1 does not 
interact with Bax, the caspase-mediated cleavage of Mcl-1 at 
Asp127 generates a fragment that induces apoptosis through 
direct interaction with Bax.399 Phosphorylation of Mcl-1 can 
affect its function and degradation.400 The phosphorylation of 
Mcl-1 is prominent in cells that accumulate in the G2/M phase 
of the cell cycle as a result of exposure to microtubule 
disrupting agents, and in synchronized cells passing through 
this phase.401 This phosphorylation, especially at serine 64, 
enhances the anti-apoptotic function of Mcl-1,400 thereby 
allowing cells to properly align their chromosomes prior to 
anaphase. In colorectal mucosa, the Mcl-1 protein is found 
in the apical cells of the crypt,402,403 whereas the distribution 
is more diffuse in the malignant cells.403
In addition to the development of apoptosis resistance, 
the loss of miR-101 also leads to cancer progression 
through the overexpression of histone methytransferase 
EZH2 (enhancer of zeste homolog 2), a polycomb group 
member, with concomitant dysregulation of epigenetic 
pathways.392,404 MiR-101 also represses the expression 
of FOS (v-fos FBJ murine osteosarcoma viral oncogene 
homolog) oncogene, a key component of the AP-1   (activator 
protein-1) transcription factor, MYCN (a gene amplified 
in many tumors), and COX-2, an enzyme involved in 
the production of prostaglandins from the metabolism of 
arachidonic acid.405 Enhanced expression of miRNA-101 
also has an effect on the late stages of cancer, since it inhibits 
invasion and migration.
The p53/p63/p73 family of tumor suppressors are known 
to regulate the major components of the miRNA processing 
complex,164,406 which include Drosha-DGCR8, Dicer-TRBP2, 
and Argonaute proteins. Drosha (RNASEN) is an RNAse III 
endonuclease; DGCR8 is a double stranded RNA binding 
protein; DICER contains an RNA helicase motif required for 
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TRBP2 (trans-activation-responsive RNA binding protein 2) 
is a component of the miRNA   loading complex (composed 
of DICER1, AGO2, and TRBP2) required for the formation 
of RISC. Argonaute proteins are endonucleases that aid in 
the maturation of pre-miRNAs of 60 to 70 nucleotides to 
mature miRNAs of 21 to 24 nucleotides; the tethering to 
mRNA mimics the miRNA-mediated repression of protein 
synthesis.164,407,408 There are 8 members of the Argonaute 
family in the human genome;409 4 belong to the PIWI 
subfamily and are expressed mainly in the testis, whereas 
the other 4 belong to the elF2C/AGO subfamily and are 
expressed in a variety of adult tissues. Ago1 and Ago2 
(catalytic engine of RISC) reside in 3 complexes with dis-
tinct DICER and RNA-induced proteins involved in RNA 
metabolism.410 Three of the 4 members of the elF2C/AGO 
subfamily are found in a tandem cluster of closely related 
Argonaute non-nucleolytic proteins,411 Ago1, Ag3, and Ago4 
on chromosome 1p (Table 4). Therefore, loss of chromosome 
1p should have a major impact on the process of miRNA 
processing in the affected cells.
A family of miRNAs on chromosome 1p of particular 
interest to colon carcinogenesis is the miR-200 family, 
which includes miR-200a, -200b, and -429 (Table 4). These 
3 family members are all encoded on a 7.5-kb polycistronic 
primary miRNA transcript and help determine the epithelial 
phenotype of cancer cells through the regulation of the 
Wnt/β-catenin signaling pathway.412,413 Wnt growth factors 
activate a cascade of intracellular events, known as the 
canonical Wnt pathway, which ultimately leads to a co-
ordinated proliferation, differentiation, and sorting of the 
epithelial cell population that forms the colonic crypts.414 
In colorectal cancer, epithelial cells that acquire mutations 
in the Wnt/β-catenin signaling pathway gain inappropriate 
proliferative capabilities mimicking the effect of a permanent 
Wnt stimulation.414 Beta-catenin is a transcription factor that 
translocates to the nucleus and activates target genes involved 
in stimulation of the cell cycle and inhibition of apoptosis. 
E-cadherin binds directly to β-catenin in the cytoplasm, 
which restricts the movement of β-catenin to the nucleus. 
ZEB1 and ZEB2 are proteins that repress the transcription 
of E-cadherin. Members of the miR-200 family were found 
to directly target the mRNA of ZEB1 and ZEB2,412,415–418 
upregulate E-cadherin expression in cancer cell lines, and 
reduce cellular motility.412 Conversely, downregulation of 
one miR-200 family member that was tested, miR-200a, 
was shown to promote tumor growth by reducing E-cadherin 
and activating the Wnt/β-catenin signaling pathway.413 
Cancer progression has some similarities with embryonic 
development and wound healing, in which a process of 
epithelial-to-mesenchymal transition (EMT) occurs.419 
Although the EMT normally occurs as a process of stem cell 
differentiation, the EMT that occurs during carcinogenesis 
involves a change from a differentiated tumor to a more 
invasive dedifferentiated tumor.412,419,420
The loss of the miR-200 family of miRNAs, coupled 
with the loss of 4 proteins associated with the Wnt/β-catenin 
signaling pathway (Table 5 below), and the loss of the pro-
apoptotic miR-34a and the miRNA transcriptional protein, 
p73, should have a significant impact on the initiation and 
progression of colon cancer.
wnt/β-catenin signaling pathway (Table 5)
The Wnt signaling pathway is critical for the differentiation 
and sorting of the epithelial cell population necessary for 
the organization of the colonic crypts and for the regulation 
of crypt cell renewal and homeostasis.414,421 Wnt signaling 
is   initiated by the binding of extracellular Wnt factors to 
  receptors on the cell surface, which triggers a signaling 
  cascade that leads to the accumulation of β-catenin.414,422 
In the absence of Wnt signals, β-catenin is degraded 
by a   multicomplex complex composed, in part, of APC 
(adenomatous polyposis coli), GSK3β (glycogen synthase 
kinase-3-beta), and the scaffold proteins Axin1 and Axin2/
conductin,423–425 forming the β-catenin destruction box. This 
destruction box is responsible for the GSK3β-mediated 
phosphorylation of β-catenin and its subsequent degradation 
by the ubiquitin-proteasome pathway. The Wnt signals 
block this phosphorylation and degradation, resulting in the 
accumulation of β-catenin. Cytoplasmic β-catenin accumu-
lation and translocation to the nucleus allows β-catenin to 
associate with TCF/LEF (T cell factor/lymphocyte enhancer 
factor) transcription factors which target genes that enhance 
cell survival and proliferation (ie, c-myc, cyclin D1).426–428 
Mutations in APC, β-catenin, Axin1, or ICAT (inhibitor 
of beta-catenin and Tcf-interacting protein) result in the 
deregulated accumulation of β-catenin and the constitutive 
activation of Wnt signaling,429–431 a major cause of cancer, 
including colorectal cancer.418,424,425,432
There are 4 genes located on chromosome 1p that are 
directly involved in the Wnt signaling pathway (CTNNBIP1, 
DVL1, WNT2B, and WNT4) (Table 5). WNT2B and WNT4 
are secreted signaling factors and Dvl1 is a cytoplasmic 
molecule that associates with Frat-1 to activate the Wnt 
signaling pathway. The loss of these positive regulators of 
the Wnt signaling pathway as a result of a chromosomal 
1p deletion may contribute to the dysregulation of crypt Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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organization that could initiate the carcinogenic process.433 
CTNNBIP1/ICAT (Table 5), on the other hand, is a 
negative protein regulator of the Wnt signaling pathway. 
ICAT disrupts β-catenin–TCF interactions,434–436 thereby 
downregulating gene expression associated with proliferation 
and cell survival. The crystallographic structure of ICAT 
indicates the mechanism by which ICAT interferes with 
β-catenin function. The NH2-terminal domain of ICAT 
binds to armadillo repeats 10–12 of β-catenin, whereas the 
COOH-terminal domain of ICAT binds to the groove formed 
by armadillo repeats 5–9.435,437 The armadillo repeats 5–9 
are crucial for the binding of β-catenin to both TCF and 
E-cadherin.438 The importance of ICAT in the prevention 
of carcinogenesis is underscored by the fact that ICAT is 
a multipotent inhibitor of β-catenin438 by interfering with 
the binding of β-catenin to TCF, cadherins, and APC, 
with consequences for transcription, cell adhesion, and 
cytoskeletal function.438–440 The cytoplasmic and nuclear 
location of ICAT, using an immunohistochemical approach, 
is consistent with a broader role for ICAT than previously 
reported.440
In addition to the effects on transcription and cell adhesion, 
ICAT can function as a pro-cell death molecule in certain 
situations. Overexpression of ICAT in colorectal tumor cells 
results in growth arrest and cell death, and serves to eliminate 
cells with a constitutively activated Wnt signaling pathway.441 
Using flow cytometry, the cell death was evidenced by a 
sub-G1 peak of the cell cycle, and the forced entry of cells 
into an illegitimate DNA synthetic phase without having 
undergone a prior mitosis (enhanced trypan exclusion 
of .4N cells).441 Transgenic mice expressing ICAT also make 
activated T cells (dependent on β-catenin–TCF signaling for 
survival442,443) highly susceptible to apoptosis (using annexin V 
staining), by reducing the expression of BclxL below a critical 
threshold.436 The mechanism by which ICAT reduces BclxL 
expression is not known at the present time.
Since chromosomal instability is a major feature of 
colon carcinogenesis, it is appropriate to consider the 
role of the Wnt signaling pathway in mitotic control and 
  aberrant Wnt signaling in the generation of chromosomal 
  aberrations. A precedent for exploring the role of aberrant 
Wnt   signaling in chromosomal instability are the findings 
that 1) multiple signaling pathways converge to orient 
the mitotic spindle in Caenorhabditis elegans embryos;444 
2) APC and EB1 (a microtubule-associated protein) have 
the ability to maintain proper spindle positioning in the 
developing nervous system of Drosophila;445,446 3)   binding of 
APC protein to microtubules increases microtubule stability 
and is regulated by GSK3β;447 4) APC has a role in chro-
mosome segregation;448 5) β-catenin is a component of the 
mammalian mitotic spindle and functions to ensure proper 
centrosome separation and subsequent establishment of a 
bipolar spindle;449 6) GSK3β has a role in mitotic spindle 
dynamics and chromosome alignment,450 and localizes to 
the centrosome and specialized cytoskeletal structures;451 
7) dishevelled genes are involved in mitotic progression in 
cooperation with polo-like kinase 1;452 and 8) conductin/axin2 
and Wnt signaling regulates centrosome cohesion.453 It is now 
well established that aberrant Wnt/β-catenin signaling can 
induce chromosomal instability in cancer, including colon 
cancer.454–458 An understanding of the mechanisms by which 
specific components of the Wnt signaling pathway affect 
mitosis, mitotic slippage and other aspects of the cell cycle, 
including interaction with spindle checkpoint proteins, needs 
to be experimentally determined.
Tumor suppressors (Table 6)
Experiments involving somatic cell fusion and chromo-
some segregation established the concept that certain genes 
are capable of suppressing tumorigenesis.459,460 Tumor 
suppressors are genes whose miRNA or protein products 
reduce the formation of tumors and prevent malignant 
progression by decreasing proliferation, regulating the cell 
cycle, maintaining chromosome integrity, enhancing DNA 
repair, inducing apoptosis, and, by reducing angiogenesis, 
invasion, migration, and cell adhesion. Classic tumor 
suppressor genes that, when deleted or mutated, contribute 
to tumorigenesis in many types of tumors include p53, RB, 
INK4a (p16), and ARF.461 In colorectal cancer, mutations 
and LOH of the tumor suppressor, APC, can affect both the 
initiation and progression of cancer, whereas the loss of p53 
is a late event. Therefore, when the loss of chromosome 1p 
became associated with many types of cancer, including 
colon cancer, several groups began the quest to identify the 
specific tumor suppressor gene or genes located on 1p.462–467 
Several genomic loci were identified as “hot spots” for tumor 
suppressor genes, which included 1p36 and 1p34. It became 
evident that many genes, both inside and outside of these “hot 
spots”, could be classified as tumor suppressors; 26 tumor 
suppressor genes, their genomic loci, and the function of 
their gene products are listed in Table 6. (Note: 11 genes 
classified as tumor suppressors in Table 6 are not listed in 
other tables [Tables 1–5 and 7]).
Several tumor suppressors are haploinsufficient,468 and 
cell cycle regulatory tumor suppressor genes seem   especially 
dosage-sensitive.469 These findings indicate that the loss of Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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only one copy of a gene in a diploid cell could have a biologic 
effect.469 Such a loss could contribute to cellular transforma-
tion, with the process of selection driving clonal expansion 
of pre-neoplastic cells.8
Certain tumor suppressors play a more prominent role in 
tumorigenesis than others in particular tissue types. However, 
it is probable that the loss of numerous tumor suppressor 
genes as a result of a chromosomal deletion probably plays 
a prominent role in the initiation and progression of cancer 
through a “combination” of different and/or complementary 
adverse cellular and molecular events.461,467
Antioxidants (Table 7)
Four genes on chromosome 1p are associated with 
defense against oxidative stress (Table 7). Two of these 
(peroxiredoxin 1 [PRDX1] and endoplasmic reticulum protein 
ERP19 [TXNDC12]) utilize reducing equivalents provided 
through the thioredoxin system, and 2 (glutamate-cysteine 
ligase [modifier subunit] or GCLM and glutathione peroxidase 
7 [GPX7]) utilize glutathione. One of the most important genes 
associated with oxidative stress is glutamate-cysteine ligase 
(GCL) (also called gamma-glutamylcysteine synthetase), the 
first rate limiting enzyme of glutathione synthesis.470,471 This 
enzyme requires coupled ATP hydrolysis to form an amide 
bond between the γ-carboxyl group of glutamate and the amino 
group of cysteine to form γ-glutamylcysteine. The enzyme 
consists of a heavy catalytic subunit (73 kDa) and a light 
(31 kDa) regulatory subunit (GCLM); the light chain or modi-
fier subunit is found on chromosome 1p. It has been known for 
the past 2 decades that the ultimate formation of glutathione 
is required for intestinal function.472 The   long-term ingestion 
of reduced glutathione has recently been shown to suppress 
the accelerating effect of a beef tallow diet on colon carcino-
genesis in rats.473 The specific importance of GCLM to protec-
tion against   oxidative stress is   underscored in GCLM (−/−) 
  knock-out mice, which are severely compromised in the 
oxidative stress response.474
GCL can be increased by oxidative stress or glutathione 
depletion475,476 through the inhibition of SHP-1477 and 
the activation of jun N-terminal kinase (JNK).477,478 The 
increase in GCL can protect against mitochondrial injury 
and numerous cellular processes that are depend on the 
generation of glutathione, such as cell cycle progression, 
inhibition of caspases (protection against apoptosis), activity 
of detoxification enzymes (see GSTM genes in Table 8; 
discussed below), and DNA repair.479–482 Recent studies 
indicate that a reduced state of proteins in the nucleus is 
an important environment that induces heterochromatin 
formation482 and the regulation of histones and PARP 
activities.483
Defense against environmental 
 and metabolic toxicity (Table 8)
Chromosome 1p contains 19 genes associated with 
protection against toxins/carcinogens derived from the 
environment, dietary/cooking-derived components, and 
metabolism (Table 8). These genes consist of 2 arylacetamide 
deacetylase-like enzymes, 4 members of the aldo-keto 
reductase family, 6 members of the cytochrome P450 
family of polypeptides, all 5 members of the mu class of 
glutathione-S-transferases (GSTs), and 2 metal response 
element binding transcription factors. A compilation of 
the 10 most significant transcripton factors capable of 
targeting the 5′-upstream promoter regions of these 19 genes 
(GeneCards [SABiosciences’ database; UCSC Genome 
Browser]) indicates the possible involvement of 95 distinct 
transcription factors that control their expression. In addition, 
the Wnt/beta-catenin signaling pathway has been shown to 
activate various P450 family and GST mu class enzymes 
in mouse models.484 Since transcription factors respond 
to different cellular demands and stresses, the presence of 
these genes on chromosome 1p indicates that the loss of this 
chromosome arm could compromise the cell’s ability to 
respond to a variety of environmental toxins/carcinogens 
that could damage DNA.
It is of interest that all 5 genes of the mu class of GSTs 
are located on chromosome 1p. The 5 genes are arranged in 
tandem in the physical order 5′-M4-M2-M1-M5-M3-3′.485,486 
The M4-M2-M1-M5 sequence in the gene cluster is oriented 
in a head-to-tail orientation, whereas the M3 gene is oriented 
tail-to-tail with respect to the adjacent M5 gene, and is 
therefore transcribed in the reverse orientation relevant to 
the other 4 GST mu genes.485 This GST mu gene cluster 
functions in the detoxification of electrophilic compounds by 
conjugating glutathione to a wide number of endogenous and 
exogenous toxins/carcinogens.487 Genetic polymorphisms 
in GSTM1 increase susceptibility to gastric and colorectal 
adenocarcinomas.488 In addition, about 70% of human loci 
is deleted for GSTM1 and 50% of the human population is 
homozygous deleted for GSTM1.485 This deletion is a result 
of unequal crossing-over between the two 2.3 kb repeated 
regions in the intergenic regions that flank the GSTM1 gene. 
Homozygous deletion of GSTM1 results in increased 
baseline chromosomal aberrations in lymphocytes among 
smokers, indicating the role of epoxides and other reactive 
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genomic instability in these compromised cells.489 All 
5 GSTM genes have distinct promoter regions that respond to 
a different array of transcription factors. Therefore, the loss of 
  chromosome 1p would compromise cellular defenses against 
toxins/carcinogens, especially in individuals harboring the 
GSTM1 deletion or other specific polymorphisms.
Development of resistance to cell death 
and the propagation of cells with DNA 
damage and chromosomal defects 
(summary)
We have described in this review how the combination of the 
persistent damage to a cell’s genome with the inability of that 
cell to adequately repair the damage or die in response to the 
excessive damage, is a dangerous situation which can result in 
clonal selection and the development of colon carcinogenesis. 
The molecular and cellular mechanisms that are associated 
with the death of cells are most complex, and include both 
caspase-dependent and caspase-independent processes. 
Listed in Tables 1–7 are 27 pro-apoptotic/pro-cell death genes 
found on chromosome 1p, whose simultaneous loss caused 
by a chromosome 1p deletion could have a major impact on 
the development of resistance to cell death. In Table 9, we 
extract from those tables the specific genes whose products 
contribute to cell death. Caspase-9 and both subunits of DNA 
fragmentation factor are on the downstream execution phase 
of apoptosis, and the consequences of their loss are obvious. 
However, the loss of other gene products (eg, TP73, miR-34a) 
can have pleiotropic effects on cell death pathways because of 
multiple transcriptional or translational targets. In addition, 
TP73, KIF1B, and E2F2 are classified as haploinsufficient 
genes, with loss of function implied with the presence of only 
1 allele.490 Some gene products have dual DNA repair/pro-cell 
death functions (eg, MUTYH) and dual mitosis/pro-cell death 
functions (KIF1B). One can see (Table 9) that, in addition to 
classic pro-apoptotic genes, there are dual role cell survival/
pro-cell death genes, DNA damage-response genes, various 
tumor suppressor genes, genes associated with mitosis, miR-
NAs, Wnt signaling, and protection against the generation 
of peroxides. The mechanism of action of these 27 genes 
in the control of cell fate is an active area of investigation 
and beyond the scope of this review. This detailed study of 
the implications of the loss of chromosome 1p serve as an 
example of how specific chromosomal   deletions can have a 
major impact on carcinogenesis.
Role of dietary factors in colon 
carcinogenesis (Table 10491–538)
In this section we first address what alteration in specific 
dietary factors can lead to the loss of chromosome seg-
ments or entire chromosome arms in general to produce 
loss of heterozygosity. Second, we will consider how the 
  consequences of the loss of genes located on chromosome 1p 
might be affected by pro-carcinogenic and anti-carcinogenic 
dietary factors. Our approach is to show how specific dietary 
factors may influence the molecular and cellular processes 
affected by chromosome 1p loss that were described in previ-
ous sections. Links of diet to any of the specific genes lost by 
the 1p deletion (see Tables 1–8) are listed in Table 10.
Diets high in fat,473,539–547 but low in fiber,540,548–551 low 
in vegetable intake,552–555 and micronutrient deficient556–560 
induce oxidative stress and DNA damage and adversely 
affect many molecular pathways that prevent genomic 
instability and apoptosis resistance, 2 major processes 
that, together, enhance the development of sporadic colon 
cancer.
Table 9 Summary of pro-cell death genes on chromosome 1p
Pro-cell death genes Reference tables
GADD54α, MUTYH, TP73 Table 1 DNA repair and DNA damage response genes
APiTD1, CCNL2, CDC2L2, CDC42, E2F2, KiF1B, PLK3 Table 2 Mitosis-related and spindle checkpoint genes
BCL2L15, BCL10, CASP9, DFFA, DFFB, THAP3, TNFRSF25 Table 3 Apoptosis-related genes
miR-34a, miR-101-1, miR-320b-1 Table 4 MicroRNAs (miRNAs) and components of the miRNA processing complex
CTNNBiP1 (iCAT) Table 5 Genes associated with the wnt signaling pathway
CHD5, DEAR1, PRDM2, NBL1, PLA2S-ii Table 6 Tumor suppressor genes
PRDX1 Table 7 Genes associated with antioxidant function
Abbreviations: APiTD1, Apoptosis-inducing, TAF9-like domain 1; CL2L15, B-Cell Lymphoma-2-like protein 15; BCL10, B-Cell Lymphoma 10; CASP9, cysteine-aspartic 
acid protease, family member 9; CCNL2, Cyclin L2; CDC2L2, Cell Division Cycle 2-like 2; CDC42, Cell Division Cycle 42; CHD5, Chromodomain Helicase DNA Binding 
Protein 5; CTNNBiP1 (iCAT), Catenin, beta interacting protein 1 (inhibitor of beta-catenin-interacting protein 1); DEAR1, Ductal Epithelium-Associated RiNG Chromosome 
1; DFFA, DNA Fragmentation Factor A; DFFB, DNA Fragmentation Factor B; E2F2, E2F transcription factor 2; GADD45α, Growth Arrest and DNA-Damage-inducible 45 
alpha; KiF1B, Kinesin family member 1B; miR-34α, microRNA-34α; miR-101-1, microRNA-101-1; miR-320b-1, microRNA-320b-1; MUTYH, MutY Homolog (E. coli); NBL1, 
Neuroblastoma, suppression of tumorigenicity 1; PLA2S-ii, The Secretory Type ii Phospholipase A2; PLK3, Polo-like Kinase 3; PRDM2, PR Domain Containing 2; PRDX1, 
Peroxiredoxin 1; THAP3, THAP domain containing; TNFRSF25, Tumor Necrosis Factor Receptor Superfamily, Member 25; TP73, Tumor Protein 73.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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Table 10 Preventive effects of dietary factors on processes and signaling pathways associated with genes located on chromosome 1p
Process Dietary factor(s) and food sources Effect(s) of dietary factors and references
DNA repair and  
DNA repair proteins
1)   Polyphenols occur in fruits and vegetables,  
wine, tea, coffee, herbs, extra virgin olive oil, 
chocolate, and other cocoa products
 
2) vitamins
1)   Stimulates DNA repair491,492 and increases levels of DNA 
repair proteins (eg, PARP-1 and PMS2) by chlorogenic acid and 
metabolites493 and GADD45 by dihydroxyphenylethanol494 and 
quercetin.495
2) Ascorbate upregulates MLH1 and p73.496
MicroRNA expression 1) Folate
 
 
 
2) Retinoids
 
3)   Curcumin (component of the indian spice, 
turmeric)
4) Polyphenols
 
5) Fish oil
 
6) vitamins
1)   Exerts cancer-protective effects through modulation of miRNA 
expression;497 rats fed a methyl-deficient diet exhibited decreased 
expression of miRNA-34a with the concomitant increase 
in E2F3.498
2)   Exert cancer-protective effects through modulation of miRNA 
expression.497,499
3)   Exerts cancer-protective effects through modulation of miRNA 
expression.497,500
4)   Quercetin and metabolites modulate inflammatory miRNA gene 
expression.501
5)   n-3 polyunstaurated fatty acids modulate carcinogen-directed  
non-coding miRNA signatures in rat colon.502
6)   Differences in dietary vitamin E affect hepatic miRNA 
concentrations in vivo.503
wnt signaling pathway 1)   Stilbenes (polyphenols) present in grapes, 
berries, peanuts, and red wine
2) Curcumin
 
 
 
 
 
3)   Triterpene lupeol found in a variety  
of fruits, vegetables, and some  
medicinal herbs
1)   Reduced nuclear and cytoplasmic immunostaining of β-catenin in 
the AOM rat model of colon carcinogenesis.504
2)   Curcumin has an inhibitory effect on wnt signaling505,506 through 
a) suppression of β-catenin response transcription activated by 
wnt3a,507 b) induction of caspase-3-mediated degradation of 
β-catenin,508 c) downregulation of p300, a positive regulator of 
the wnt/β-catenin pathway,507 d) reduction of expression of the 
Frizzled-1 wnt receptor.509
3)   Lupeol treatment resulted in a) an increase of apoptosis,  
b) a decrease in β-catenin transcriptional activity, c) a restriction  
of the translocation of β-catenin from the cytoplasm to the nucleus, 
d) a decrease in expression of the wnt target genes, c-myc, cyclin 
D1, e) a decrease in expression of the proliferation markers, 
PCNA, Ki-67, and f) a decrease in expression of the invasion 
marker, osteopontin.510
Antioxidant
gene
expression
1) Polyphenols (eg, red wine, black tea)
 
 
2) Curcumin
 
3) Diterpenes (eg, kahweol, cafestol)
1)   Activate endogenous antioxidant defense systems, which include 
the glutathione peroxidases;511,512 enhancement of glutathione and 
γ-glutamylcysteine synthetase.513–517
2)   Curcumin alters EpRE and AP-1 binding complexes and elevates 
glutamate-cysteine ligase expression.518
3)   The coffee-derived diterpenes (eg, kahweol, cafestol) can induce 
γ-glutamylcysteine synthetase and glutathione levels in the liver, 
kidney, lung, and colon of the rat.519
Environmental/
metabolic
toxicity genes
1) Polyphenols and orto-phenols
 
 
2) Diallyl disulfide (DADS)
 
3) Butyrate
4) Diterpenes (eg, kahweol, cafestol)
1)   Activate endogenous detoxification defense systems,511,520 including 
GSTM2;513 p-coumaric acid, a coffee compound.521 can increase the 
mRNA levels of GSTM2.522
2)   DADS increases tissue activities of quinone reductase and 
glutathione transferase in the gastrointestinal tract of the rat.523
3)   Butyrate can induce GSTM2 expression in human colon cells.524
4)   The coffee-derived diterpenes (eg, kahweol, cafestol)521  
can enhance glutathione S-transferase activities.519,525
Oxidative DNA
damage
1)   Polyphenols include flavonoids (quercetin, 
luteolin, kaempferol, naringenin; myricetin), 
oleuropein, protocatechuic acid, hydroxybenzoic 
acids, flavones, hydroxycinnamic acids, lignans,  
anthocyanins, isoflavones, stilbenes,  
propanoid glycosides, chlorogenic acid,  
and metabolites
1)   Polyphenols have the capacity to act as antioxidants (chain breakers 
or free radical scavengers,526 thereby preventing the induction of 
oxidative DNA lesions,527–530 and stimulating DNA repair;492 black 
tea complex polyphenols inhibit 1,2-dimethylhydrazine-induced 
oxidative DNA damage in rat colonic mucosa;531 4-coumaric acid, 
a coffee component, can reduce oxidative DNA damage in rat 
colonic mucosa.522
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The effects of diet likely occur early in the carcinogenesis 
process, since an altered vegetable intake is known to affect 
pivotal carcinogenesis pathways in the colonic mucosa 
from adenoma patients and controls.561 Although 2 alleles 
are associated with each gene, and the loss of 1 allele may 
be compensated for by the other, many genes are reported 
to be haploinsufficient, including those associated with the 
mitotic checkpoint.562 It is relevant that TP73, KIF1B, and 
E2F2, found on chromosome 1p, have also been reported 
to be haploinsufficient,490,563,564 and could have dramatic 
  consequences for colon tumorigenesis if only 1 allele is 
expressed in colonic epithelial cells. It is possible that many 
other genes may be found to be haploinsufficient in the 
future, since a map of 1079 probable haploinsufficient genes 
has been compiled by systematic identification of genes 
unambiguously and repeatedly compromised by copy number 
variation among 8458 apparently healthy individuals.565 Those 
genes with a high probability of exhibiting haploinsufficiency 
were enriched among genes implicated in human dominant 
diseases and among genes causing abnormal phenotypes 
in heterozygous knockout mice.565 In addition, the loss of 
several genes on the same chromosome arm that affect a 
particular molecular pathway (see Tables 1–8) may together 
have a significant effect on that pathway, although the loss of 
a single gene may have little effect. Specific dietary factors 
may decrease the protein levels of certain genes through 
post-translational mechanisms (eg, proteasomal degradation), 
thereby inducing a functional pseudo-biallelic loss of a gene, 
one through a physical loss of the chromosomal segment 
harboring that gene, and the other an actual degradation of 
the gene product.
Although dietary factors may affect many processes 
associated with carcinogenesis, we will evaluate specific 
factors associated with oxidative stress/inflammation, 
since these genotoxic processes are known to have major 
effects on the initiation and progression of cancer, including 
colon cancer.566–578 Direct damage to DNA, assessed by 
immunohistochemical staining of 8-oxoG, correlates 
with poor survival in colorectal cancer.579 ROS can cause 
excessive DNA double strand breaks, resulting in the loss 
of chromosome segments or entire arms, depending on 
the location of the break. In addition, several DNA repair 
  proteins are degraded through an oxidative mechanism,580,581 
thereby affecting DNA repair and increasing susceptibility 
to   cancer.582 Oxidative stress can affect spindle organization, 
induce centrosome amplification, cause proteolysis of 
  components of the   anaphase-promoting complex, and 
  override the spindle checkpoint, thereby   affecting chro-
Table 10 (Continued)
Process Dietary factor(s) and food sources Effect(s) of dietary factors and references
2)   Fish oils, such as docosahexaenoic acid  
(DHA), eicosapentaenoic acid (EPA)
3)   Monounsaturated fatty acid (eg, oleic acid) 
obtained from olive oil.
 
 
 
 
 
 
 
4) Short-chain fatty acids (eg, butyrate)
 
 
 
 
5)   Garlic organosulfur compounds (OSC),  
such as allicin, diallyl sulfide, diallyl disulfide, 
S-allyl cysteine, allyl mercaptan, are derived 
from garlic
6) vitamins
2) Fish oils reduce oxidative DNA damage in rat colonocytes.532 
 
3)   in a study of the effect of olive oils on biomarkers of oxidative DNA 
stress in Northern and Southern Europeans, 25 mL of 3 olive oils 
with low, medium, and high phenolic content were administered to 
182 males daily for 3 weeks, resulting in a significant reduction of 
DNA oxidation by 13%.533 The olive oil intake led to marked increase 
in monounsaturated fatty acid intake independent of the phenolic 
compounds; lifelong feeding of monounsaturated fatty acid-rich olive oil 
led to a lower level of oxidative DNA damage and DNA double strand 
breaks compared with polyunsaturated fatty acid-sunflower oil.534
4)   Pre-incubation of normal human colonocytes ex vivo and HT-29 
colon cancer cells in vitro with physiological concentrations of 
butyrate reduced H2O2-induced DNA damage using the comet 
assay;535 butyrate protects human colon cells from genetic damage 
by 4-hydroxynonenal.536
5)   OSC decreased the genotoxicity of hydrogen peroxide and 
methanesulfonate, assessed using the comet assay.537
 
 
6)   Ascorbic acid (vitamin C) protects against endogenous oxidative 
DNA damage.538
Abbreviations: AOM, azoxymethane; AP-1, activator protein 1; c-myc, avian myelocytomatosis viral oncogene homolog; DADS, diallyl disulfide; DHA, docosahexaenoic 
acid; E2F3, E2F transcription factor 3; EPA, eicosapentaenoic acid; EpRE, electrophile response element; GADD45, Growth Arrest and DNA-Damage-inducible 45; GSTM2, 
Glutathione S-Transferase Mu 2; Ki-67, antigen identified by monoclonal antibody Ki-67; miRNA-34a, microRNA-34a; MLH1, mutL homolog 1; mRNA, messenger ribonucleic 
acid; OSC, organosulfur compounds; P73, Tumor Protein 73; PARP-1, poly(ADP-ribose) polymerase-1; PCNA, proliferating cell nuclear antigen; PMS2, postmeiotic segregation 
increased 2; wnt, wingless-type.Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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mosomal stability. Therefore, oxidative stress can induce 
a mutator phenotype in affected cells.583 The big question 
is what dietary factors contribute directly to   oxidative 
DNA damage and aneuploidy (alteration in the number of 
whole chromosomes or chromosomal segments). We now 
address several dietary factors that may be   associated with 
these forms of genomic instability. Although the literature 
on dietary factors associated with genomic instability is 
substantial, we have chosen to discuss the effects of a high-
fat diet, folate deficiency, and niacin deficiency, since the 
molecular and cellular mechanisms associated with the 
overabundance or deficiency of these factors have been 
especially well studied.
A high-fat diet derived from beef tallow or corn oil 
(eg, linoleic acid, palmitic acid) is one of the major causes of 
sporadic colon cancer. Long-chain nonesterified (“free”) fatty 
acids (FFA) and some of their derivatives and metabolites 
can modify the intracellular production of ROS, in particular 
superoxide anions and hydrogen peroxide, in part, through 
their interference with the mitochondrial electron transport 
chain.584 FFA can also interfere with the glutathione system 
and stimulate the generation of superoxide anions from 
phagocytic NADPH oxidases.584 Chronic exposure of cells 
to FFA (eg, palmitic acid) can also alter miRNA expression 
(eg, miR-34a, miR-146).585
The genotoxicity associated with a high-fat diet is also 
caused, in part, by high concentrations of hydrophobic bile 
acids released into the gastrointestinal tract in response to 
high-fat meals where they act as detergents to aid in the 
digestion of fats. Our research group showed that deoxycholic 
acid (a major hydrophobic bile acid in the human colon) 
induces ROS586–589 in vitro, and oxidative DNA damage,590 
sessile adenomas,591 and colon cancer592 in dietary-related 
mouse models. In addition to the bile   acid-induced formation 
of 8-oxoG in guanine bases of DNA and the induction of 
DNA strand breaks (activation of γ-H2AX593 and PARP594), 
we have shown that deoxycholic acid affects genomic 
instability at the chromosomal level.595 Evidence indicating 
the induction of chromosomal damage by deoxycholic acid 
include the formation of micronuclei and aberrant mitoses, 
attenuation of activation of the nocodazole-induced spindle 
checkpoint, and decrease in protein expression of major 
spindle checkpoint proteins (eg, Mad2, BubR1, securin). The 
dramatic effect of deoxycholic acid on the process of mitosis 
is underscored by the finding that deoxycholic acid modulates 
71 mitosis-related genes at the mRNA and/or protein levels 
in vitro and in vivo using mouse models.8 The induction 
by hydrophobic bile acids of both DNA and chromosomal 
damage indicates that hydrophobic bile acids are endogenous 
carcinogens that, at high pathophysiologic concentrations, 
are capable of contributing to the initiation and progression 
of colon cancer.8,189,595–597 In addition to causing genomic 
instability, deoxycholic acid can activate survival pathways 
(eg, NF-κB594 and autophagy598), which allow for the survival 
and selection of cells with genomic instability.8,599
Coffee drinkers have a lower incidence of cancer, 
including that of the colon and rectum.600–603 One coffee 
compound that we found to prevent the formation of bile 
acid-induced proximal colon cancer in a mouse model is 
chlorogenic acid (CGA), the ester of caffeic acid with quinic 
acid.592 CGA is one of the most abundant polyphenols in the 
human diet, with coffee, fruits (eg, blueberry, strawberry, 
raspberry, apple), and vegetables (eg, eggplants, potato, 
carrot, tomato) as its major sources.493,604 CGA and its 
metabolites are likely responsible, in part, for the lower 
risk of rectal cancer associated with the consumption of 
decaffeinated coffee in 2 large prospective cohort studies.603 
One possible mechanism by which polyphenols can reduce 
colon cancer in this model is through the reduction in 
deoxycholic acid levels.605 In this study, Han et al605 report 
that when rats on a high-fat diet (30% beef tallow) received 
dietary curcumin (component of the Indian spice turmeric) 
or caffeic acid (metabolite of CGA), the fecal concentration 
of deoxycholic acid was substantially reduced. In addition, 
dietary supplementation of this high-fat diet with caffeic 
acid, catechin (plant polyphenol), rutin (citrus flavonoid 
glycoside), and ellagic acid (plant polyphenol) significantly 
reduced the levels of fecal lithocholic acid, a second major 
hydrophobic bile acid and risk factor for colon cancer.605
The induction of double-strand breaks is a major cause of 
the production of chromosomal fragments and the deletion 
of hundreds to thousands of genes. An important DNA repair 
protein in preventing large chromosomal deletions is Parp-1606 
(Figure 5). DNA strand breakage is directly caused by ROS 
(which would be enhanced due to the loss of genes encoding 
antioxidant proteins in the chromosome 1p deletion [Table 7]) 
or as a result of the activity of base excision repair enzymes 
(see Figure 5). Strand breakage activates Parp-1, which is 
involved with opening up chromatin and allowing DNA repair 
processes to occur, including base excision repair, single-
strand and double-strand repair (Figure 5). Shibata et al606 
carried out mutation analysis using Parp-1 knockout (Parp−/−) 
mice, and found that PARP deficiency enhanced deletion 
mutations, especially .1 kbp. A dietary micronutrient whose 
deficiency has a major effect on PARP activity is niacin 
(vitamin B3) obtained from meat and corn. The term niacin Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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refers to nicotinic acid and nicotinamide, which are both 
used by humans to form NAD+. PARP-1 utilizes NAD+ to 
make poly(ADP-ribose) needed for poly(ADP-ribosyl)ation 
of proteins. In keeping with the protective effect of PARP, we 
determined that pre-treatment of cells in vitro with nicotinic 
acid and nicotinamide protected against bile acid-induced 
apoptosis,607 presumably by enhancing PARP-mediated DNA 
repair of bile acid-induced DNA damage and replenishing 
the NAD+ levels in mitochondria. In addition, we showed that 
pre-treatment of cells with nicotinic acid and nicotinamide 
upregulated the mRNA levels of the glycolytic enzymes, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 
glucose-6-phosphate dehydrogenase (G6PD).608 GAPDH 
and G6PD may protect against oxidative stress, in part 
through the generation of the reduced pyridine nucleotides, 
NADH and NADPH, respectively, from NAD+.608 Niacin 
supplementation was even reported to improve pellagra 
(severe niacin deficiency) in a patient with Crohn’s disease,609 
a pre-cancerous inflammatory condition610 associated with 
oxidative DNA damage.611 Pellagra most probably developed 
in these Crohn’s disease patients through a combination of 
intestinal malabsorption of niacin/nicotinic acid612,613 and 
the high demand for NAD+ that accompanies DNA damage-
induced PARP-1 activity (see Figure 5). Work from our 
laboratory indicated that CGA and its metabolites, caffeic 
acid, m-coumaric acid, and 3-(m-hydroxyphenyl) propionic 
acid, increased PARP-1 protein expression.493 The modulation 
of PARP-1 protein levels by CGA may explain, in part, the 
colon cancer preventive properties of CGA when added as 
a supplement to the bile acid-induced colon cancer mouse 
model.592
The mechanisms by which chromosome segments are 
deleted and translocated can be most complex. Deletions 
and translocations can arise from centromeric instability and 
telomeric instability.7,614 and have been proposed as possible 
mechanisms for chromosomal aberrations associated with 
chromosome 1.615–617 Centromeric instability can result 
from hypomethylation or acetylation of pericentromeric 
heterochromatin, resulting in decondensation/uncoiling/
disruption of the centromere618–620 and loss of the affected 
chromosome arms. Telomeric instability is characterized 
by telomeric fusions, formation of anaphase bridges during 
mitosis, broken chromosomes upon the stress of cell division, 
and fusion of chromosomal fragments to chromosome 
ends. This cycle of chromosomal abberations is referred 
to as breakage–fusion–bridge cycles.107–114,621 Six genes 
found on chromosome 1p (APITD1, CCDC28B, CDCA8, 
HDAC1, KIF2C, RCC2) are associated with centomeres (see 
Table 2), and whose loss would affect centromeric instability. 
A deficiency of HDAC1, for example, has been reported to 
disrupt pericentromeric heterochromatin.622 In addition to its 
role in the repair of interstrand cross-links,623 APOLLO (aka 
DCLRE1B [DNA cross-link repair 1 B]) is also involved 
in the protection of telomeres (see Table 1). APOLLO is 
stabilized when bound to the telomere-binding protein 
TRF2, and protects human telomeres in S phase624 (Figure 4). 
A reduced level of APOLLO results in an increased number 
of telomere-induced DNA damage foci and telomeric fusions 
in S-phase,624 suggesting that APOLLO contributes to a 
processing step associated with the replication of chromosome 
ends. Hydrophobic bile acids, probably through the generation 
of oxidative stress, can modulate 71 genes associated with 
mitosis8 and decrease the protein expression of 3 major 
spindle checkpoint proteins (eg, Mad2, BubR1, securin).8 
These alterations in gene expression, coupled with direct 
oxidative damage to components of the mitotic apparatus, 
may be responsible, in part, for the observed bile acid-induced 
mitotic aberrations.595 It is, therefore, possible that bile acids 
may contribute to the loss of chromosome 1p through its 
effects on centromere instability and telomeric fusions.
Another mechanism by which large chromosomal 
deletions can occur is through folic acid deficiency.625,626 
Folic acid can attenuate the loss of heterozygosity of the 
DCC tumor suppressor gene in the colonic mucosa of 
patients with colorectal adenomas,625 indicating that folic 
acid deficiency can affect allelic deletion and associated 
micronuclei formation.627,628 Folates are a group of water-
soluble B vitamins (obtained from leafy, green vegetables, 
the whole grain quinoa, and lentils) whose deficiency 
contributes to colon cancer.629–633 Folates maintain DNA 
stability through their ability to donate one-carbon units for 
cellular metabolism and particularly for DNA biosynthesis, 
repair, and methylation.629,633 Methylenetetrahydrofolate 
reductase (MTHFR) is a key enzyme in one-carbon 
metabolism. MTHFR catalyzes a unidirectional reaction 
that determines the balance between cellular availability 
of 5,10-methylenetetrahydrofolate, used for thymidylate 
and purine synthesis, and methyltetrahydrofolate used 
for biological methylation.629 Folate deficiency, therefore, 
enhances carcinogenesis by impairing normal methylation 
and nucleotide synthesis, and creates an imbalance between 
the partitioning of cellular folates into these two pathways. 
Inhibition of folate metabolism results in excessive uracil 
misincorporation into DNA633,634 with approximately 4 million 
uracil bases/cell.559 The repair of 2 adjacent uracil residues on 
opposite strands of DNA can result in a double-strand break, Clinical and Experimental Gastroenterology 2011:4 submit your manuscript | www.dovepress.com
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leading to chromosomal breakage and aneuploidy.558,629,634 
Folate deficiency also induces hypomethylation and inhibits 
DNA excision repair in immortalized normal human colon 
epithelial cells633 and in the rat colon.635
Recent studies have implicated folate deficiency in the 
modulation of miRNA expression.497,636 Using microarrays 
of 385 known human miRNAs, it was determined that folate 
deficiency in vitro in cultured cells induced a statistically 
significant fold-change in 24 miRNAs.636 One of these 
miRNAs was miR-34a, which is found on chromosome 1p 
and involved in p53-mediated signaling (see Table 4 and the 
section on MiRNA and MiRNA Processing). MiRNAs were 
also determined to be altered in patients on a folate-deficient 
diet.636 In addition to folate deficiency, polymorphisms 
of MTHFR and altered folate levels are associated with 
colon cancer risk.637–640 The fact that MTHFR is located on 
chromosome 1p at 1p36.22 indicates that the loss of this 
chromosome arm, coupled with folate deficiency, can have 
major effects on genomic instability.
In this section we have considered how dietary factors such 
as niacin, folic acid, and a low-fat diet associated with low 
bile acid levels, together with antioxidants that protect against 
oxidative DNA damage (Table 10), might affect the processes 
relevant to carcinogenesis that are altered by chromosome 1p 
loss. In addition to a deficiency in dietary factors that prevent 
oxidative DNA damage, a deficiency of certain dietary fac-
tors that modulate DNA repair proteins, miRNA expression, 
antioxidant enzymes, defenses against environmental toxicity, 
and the Wnt signaling pathway (Table 10) can exacerbate the 
effects of the loss of chromosome 1p. An understanding of the 
complex molecular and cellular pathways that are affected by 
dietary factors is an enormous undertaking, but one that has 
become a focus of colon cancer prevention.
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